The chemistry of some fused eight-membered heterocyclic systems by Gunawardana, IWK
THE CHEMISTRY OF SOME FUSED 
EIGHT—MEMBERED HETEROCYCLIC SYSTEMS 
, by 
I.W.K. GUNAWARDANA, B.Sc. 
Being a Reading Thesis submitted as 
part requirement of the preliminary 
studies for the Degree of Master of 
Science at the University of Tasmania 
Chemistry Department 
University of Tasmania 
August, 1980. 
Contents 
Acknowledgement 
page 
Chapter 1 . ' Introduction 1 
Chapter 2 Benzazocines 6 
Chapter 3 • Benzodiazocines 41 
Chapter 4 Benzoxazocines 65 
Chapter 5 Dibenzazocines 78 
Chapter 6 Dibenzodiazocines 105 
Chapter 7 Dibenzoxazocines 144 
References 152 
Acknowledgement 
I am grateful to Drs. J.B. Bremner and E.J. Browne for 
continued guidance and assistance during the course of this work. 
My thanks are extended to Mrs. J. Watson (Maths. Department) 
for calculating the possible isomers of benzo-fused ring systems. 
I also wish to thank Mrs. B. Thomson for typing the thesis, 
and my husband for encouragement given to me during this work. 
Chapter 1  
Introduction  
It has been attempted in this thesis to compile information 
available in the literature on the synthesis of some eight-membered 
heterocyclic ring systems fused with one or two benzene rings 
(benzo- and dibenzo- respectively), having one nitrogen (azocines), 
two nitrogens (diazocines), and one nitrogen and one oxygen 
(oxazocines) in the ring system. Literature up to the end of 1978 
has been covered. 
While this work was in progress, a similar report appeared in 
Rodd's Chemistry of Carbon Compounds, Volume IV - K. 1 This review 
article covers the literature up to the end of 1972 only and does 
not include oxazocines. 
With the growing interest in the pharmacological activity of 
medium rings, synthetic work in this area has seen a remarkable 
increase during the 1970's. Figures 1 and 2 show the distribution of 
publications during the period covered in this thesis, and it is 
evident that a large amount of work has been carried out after 1972. 
Synthetic work on dibenzodiazocines has been reported from the early 
1880's, but only six publications appeared up to the end of 1920. 
Relative positions of the hetero atoms and the ring fusion give 
rise to a number of structural isomers in each benzo- and dibenzo-
system. The number of possible isomers and the number of isomers 
reported (to the end of 1978) in each case is given in Table 1. All 
the structural isomers of benz- and dibenzazocines are known, whereas 
those ring systems containing nitrogen and . oxygen, oxazocines, are 
less well known and should provide a fertile area for future synthetic 
2 
endeavours. 
The calculation of the number of isomers possible for the benzo-
fused eight-ring systems, was based on the following general 
equation: 
A-M 
Total Number of Isomers = (-2-) + M 
where, 
P!  
A = PIPIP1 
C" N" 0' 
and M equals the number of arrangements in the ring in which 'mirror 
symmetry' is shown about the central horizontal line. Hence, for 
one nitrogen atom, M = 0, for two nitrogen atoms, M = 3 and for 
nitrogen and oxygen, M = 0. In the calculation of A, P is the number 
of possible replacement sites (6) in the eight-membered ring, while 
P
C' 
P
N 
and P
0 
 are the numbers of carbon, nitrogen and oxygen atoms 
(if present) respectively. 
The number of isomers for the dibenzo systems were worked out 
manually. 
The nomenclature of all these ring systems is as given in 
Chemical Abstracts. 	The synthesis of each group is discussed 
separately in the following Chapters, and each Chapter is divided 
according to the methods employed to construct these ring systems. 
An attempt has been made to include not only the basic synthetic work, 
but also further functional group manipulations together with key 
pharmacological properties of the azocines, diazocines and oxazocines 
fused with one or two benzene rings. 
3 
Table 1  
Type of compound Number of 
possible isomers 
Number of 
known isomers 
azocines 3 3 
Benz(o) diazocines 9 7 
oxazocines 15 7 
azocines 6 6 
Dibenz(o) diazocines 11 5 
oxazocines 16 8 
15 
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Chapter 2  
Benzazocines  
All three structural isomers of benzazocines are known and the 
widely prepared isomer is the 1-benzazocine (Figure 3). 
1 	2 
1-Benzazocine 2-benzazocine ' 3-benzazocine 
(A) (B) (C) 
Figure 3 
Methods of Preparation  
The construction of 1-, 2-, and 3-benzazocine derivatives can be 
divided into three major groups according to their methods of 
preparation. These are, 
(A) ring enlargements 
(B) ring closure, and 
(C) photocyclization. 
(A) Ring enlargements  
The expansion of smaller rings to heterocyclic eight-membered 
rings has been achieved by, 
(i) rearrangements 
(ii) ring enlargement by cleavage of an internal C-C or C-N bond, 
and, 
(iii) addition followed by ring enlargement. 
7 
A( 1) Rearrangements  
A(i) (a) Beckmann rearrangement  
A(i)a-(1) 1-Benzazocines  
The Beckmann rearrangement is a widely used method for the 
synthesis of 1-benzazocines. In many cases the precursors are 
7H-benzocycloheptene-5-one (1) 2 ' 3 or 5,6,7,8-tetrahydro-7H-
benzocycloheptene-5-ones (2-9) 4-15 (Table 2). 
(1) 
	
(2-9) 
In theory, the Beckmann rearrangement of asymmetrical ketones 
can form a mixture of isomeric products, due to the concurrent alkyl 
and aryl migration. In addition, fragmentation of the oxime also may 
occur during the rearrangement. However, in the above cyclic ketones, 
formation of only one isomer was reported. 
For example in the rearrangement of benzocycloheptanone oximes, 
only phenyl migration occurred rather than alkyl migration resulting 
in 1-benzazocine-2-ones.
4
'
5 	
This was shown by hydrolysis of the 
lactams followed by diazotization and f3-naphthol coupling. 
The oximes (1) and (2-9) were rearranged in the presence of a 
suitable dehydrating agent such as polyphosphoric acid,
4 
phosphorus 
pentachloride or sulfuric acid
6,7 
to yield the corresponding 1- 
benzazocine-2-ones (12-20). The general reaction is illustrated in 
Scheme 1. 
Ketone 
(2-9) 
(12b) 
8 
NOH 
0 
 
(oxime) (12-20) (21) 
	
(10) 
	
(lactams) 
Scheme 1 
Many substituted lactams were prepared in high yields by the 
Beckmann rearrangement. Then these lactams were converted into many 
other derivatives by reduction and alkylation.
16 
The 1-benzazocine-2- 
(1H)-thione (12b) was prepared by the reaction of (12a) and thioacetic 
acid.
17 
Attempts to prepare 10-substituted hexahydro-l-benzazocines 
were unsuccessful, however, but no explanation was given.
6 
The yields and conditions employed in the Beckmann rearrangement 
are given in Table 2. 
A(i)a-(2) 2-Benzazocines  
Unlike the 1-benzazocines, the application of the Beckmann 
rearrangement to the synthesis of 2-benzazocines is limited. The 
only case reported, by Huisgen and co-workers,
11 
was the preparation 
of 2-(2,4,6-trinitro)-2-benzazocine-1(21)one (25a) in 84% yield by 
the rearrangement of the syn-oxime (24) in dichloromethane. When the 
9 
Table 2  
A(i)a-(1) 1-Benzazocines  
Beckmann rearrangement  
Starting material Reaction conditions Product(s) Yield 
% 
Ref. 
, 
_ 
(4) 
(5) 
(6) 
(7) 
(8) 
(9) 
(10) 
(1) 
(2) R 
(3) R=6-C1 
R
2 
el. 
R=7-C1 
R=8-NO2 
R=8-C1 
R2=R3=CH3 
R1 =C6H5 
(oxime) 
o 
R 
I 3 
I 	R 
=R 1 =R 2=R3=H 
+R
3 
 =-(CH ) - 
2 2 
(i) 
(ii) 
(i) 
(ii) 
(i) 
(ii) 
(A) (1) 
(2) 
NH2OH/pyridine 
Et0H A, and 
C6H5S02C1 
0°-room 
temperature 
'NH2OH/pyridine 
Et0H and 
H2SO4/glacial 
acetic acid 
(2:1) or 
6,7 
C
6 H 5  SO2  Cl 
'NH 20H/pyridine' 
Et0H, and 
polhosphoric yp 
acid
4 
 or PC1 
5
5 
pyridine/HC1 and 
C
6 H 5 
 SO
2 
 Cl 
acetone/pyridine 
picryl chloride 
CH2C1 2 and 
011 
.3 
=R3=R4=H 
R2 
68 
59 
88 
85' 
90 1 
29 
50, 
98' 
92] 
80 
80 
2 
3 
6,7 
6 
4 
9,10 
11 
11110 
N 
R1 4 
R 
(12 
R=R1=R2 
(13)R=7-C1 
(14)R=8-C1 
(15)R=9-NO2 
(16)R=9-C1 
(17)R
2 
 =R
3 
(18)R
2 
 +R
3 
(19)R1 =C6H5 
(20)R4=-S0j 
N 
i 
=CH3 
=-(CH 2 ) 2 - 
2‘ ?CH 
1 0 
Table 2 continued 
(B) p-CH3C6H4S02C1 or 
CH3SO2Cl 
(10) 	(oxime) 
11110 
_ LiA1H4/A1C1 3 (22) R5=S02-C6H4 C1-2_ 75 12 
(10) 	(oxime) LiA1H4/ether (23) R5=H - 13-15 
t when not specified, Rn=H (n=1,2,3  
anti-oxime was used, the formation of a 1-benzazocine derivative was observed. 
Therefore the direction of the migration was determined by the configuration 
of the oxime as has been noted in other systems.
2-6 
(24) C25a) 1-70 
R=2,4,6-trinitro 
(25h) fZ=S 
R=H 
The reaction of (25a) with thioacetic acid, gave the 2-benzazocine-1- 
(2H)thione (25b).
17,18 
The preparation of 3-benzazocines by the Beckmann rearrangement 
has not been reported although this should provide a convenient route 
11 
to these systems. 
A(i)b Schmidt reaction  
A(i)b-(1) 1-Benzazocines  
The Schmidt reaction has also been employed to synthesise various 
1-benzazocine derivatives from benzocycloheptanones. When an 
appropriate cyclic ketone (2) was treated with a mixture of hydrazoic 
acid and sulfuric acid, it underwent both aryl and alkyl migration to 
produce a mixture of two isomeric products (12 and 21) respectively. 
Another side reaction, the formation of fused tetrazole, (26), may 
also occur (Scheme 2). 
HN3/H2SO4  
(2) > (12) + (21) + 
(1: 1) 
. Scheme 2 
However, many workers
19,20 
have observed that the aryl migration 
in seven-membered bicyclic ketones is favoured over alkyl migration, 
resulting in a higher yield of 1-benzazocine derivatives. The 
reported alkyl migration of benzocycloheptanone was only 20%.
19 	
It 
has been found when five- and six-membered benzo fused ketones having 
electron releasing substituents are subjected to the Schmidt reaction, 
the alkyl migration is greater than the aryl migration; conversely 
electron withdrawing substituents favour aryl migration. The use of 
trichloroacetic acid or polyphosphoric acid was also found to increase 
the aryl migration products. However these effects on the aryl 
migration was less with benzocyclohpetanones, because of the flexibility 
(2) 
< 
 HN3  /H SO 2 4 
NaN3/HC1 
> (12) 
> (26) 
12 
of the seven-membered ring.
19 
Huisgen
22 
has reported that under the more usual Schmidt reaction 
conditions, i.e. hydrazoic and sulfuric acid in benzene, 5,6,7,8- 
tetrahydro-7H-benzocycloheptene-5-one (2) gave the ring expanded 
tetrazole (26, R=H), whereas 1-tetralone (27) yielded the expected 
seven-membered lactam (28). Replacing the sulfuric acid with 
hydrochloric acid,
21 
the ketone (2) did yield the expected lactam (12). 
40, 
(27) (28) 
Therefore it is evident from these contrasting results, that the 
Schmidt reaction is more sensitive than the Beckmann rearrangement to 
the conditions used, and that the former is less satisfactory as a 
preparative method. 
The synthesis of 1-benzazocines by the Schmidt reaction is shown 
in Table 3. 
A(i)b-(2) 2-Benzazocines  
A low yield (20%) of 2,4,5,6-tetrahydro-2-benzazocine-1-(2H)-one 
(21), (R=H) was obtained by the Schmidt reaction of the ketone (2). 19 
As described for 1-benzazocines, the major product was the lactam (12) 
which was formed by the aryl migration. Hence the Schmidt reaction is 
3/ - 2 -- 4 HN H SO 
  
13 
Table 3  
A(i)b-(1) 1-Benzazocines  
Schmidt reaction  
Starting material Reaction conditions Product(s) Yield % Ref. 
111111 
(2) R=R1 =H 
(29) R=7-0CH 3 
(30) R=7,8-(OCH 3 ) 2 
1 R =pC1.C6H4 - 
(A)H2SO4/NaN3 
60-64° 
or 
(B)molten CC1 3COOH 
NaN3 
or 
(C)PPA/NaN318 
or 
(D)NaN3/methane 
sulphonic acid 19 
or 
(E)HC1/NaN3 , 
below 8°C 20,22 
or 
(F)CHC1 3/HN3 /H2SO4 21 
NaN 3/H2SO4 
r 
80-82 
80 
- 
2 	- 
9,19-21 
23 
19 
22,24 
25 
(12) 
(31) 
(12) 
(32)[ 
.,, 
x s 
R=R1 =H 
R=8-0CH3 
+ (26) 
R=8,9-(OCH 3 ) 1 R=C6H4 -C1.2. 
14 
not suitable for the preparation of 2-benzazocine derivatives. 
A(i)b-(3) 3-Benzazocines  
The Schmidt reaction of 5,6,7,8-tetrahydro-7H-benzocycloheptene-7- 
one (33) gave the expected lactam (34) in 88% yield, on treatment 
with sodium azide and hydrochloric acid.
6,21,26 	
The formation of 
isomeric products and tetrazoles or other side reactions were not 
reported 
6 , 21 
(33) 
	
(34) 
A(ii) Ring enlargement by cleavage of an internal C-C or C-N bond  
A(ii)-(1) 1-Benzazocines  
The ring enlargement of cyclopent[]indoles (35-43) and pyrrolo-
[1,2-a]-indoles (44-46) to 1-benzazocines is one of the most widely used 
methods. 
(44-46) 
The oxidative cleavage of cyclopentWindoles by sodium periodate 
gave the 1-benzazocine-2,6-diones (47-55).
27-34 	
(Table 4). This 
reaction proceeds through the formation of an intermediate hydroperoxide. 
The cyclopentWindoles are highly unstable in solution and undergo 
rapid auto-oxidation to give the final product (47), and the 
intermediate hydroperoxide was not isolable.
29 	
With higher analogues 
CH30 
CH3 
CNBr 
(57) R=Br, RCN 
Na 2CO3  
> (59) R=C1, R1=CO2C2H5 
0 
H COOH/(CH,C0),0 1 
") 	4 > (58) R=OCCH3'. R =COCH3 
ethyl chloroformate 
15 
of cycloalkylindoles this intermediate can be isolated, and they form 
mixtures of ring expanded lactams together with highly oxygenated 
products which were not investigated further. 
(1) [0]  
(35) 
(ii) 1-14. 
j\) 
These 2,6-dione derivatives were converted into 6-hydroxy 
derivatives by the action of phenyl magnesium bromide followed by 
reduction with lithium aluminium hydride.
35-37 
The von Braun reaction of pyrrolo[1,2-ajindoles (44,46) gave the 
1-benzazocine derivatives in moderate yields.
38-42 	
(Table 4). 
Kametani and co-workers
41 
have reported an alternative 
transformation of the pyrrolo[1,2-a3indole (45) into 1-benzazocines 
(57-59) in good yields using ethyl chloroformate and sodium carbonate 
or acetic anhydride and acetic acid. (Scheme 3). 
Scheme-3 
(61,62) 
A C 6H6 
CO
2
CH
3 
CO
2
CH
3 
CH CO CC-00 CH 
3 2 ' .2 3' 
A 
16 
The ring enlargements of cyclopentftlindoles and pyrrolo[1,2-Ajindoles 
are summarized in Table 4. 
A(iii) - Addition followed by ring enlargement  
A(iii)-(1) 1-Benzazocines  
In recent years dimethylacetylenedicarboxylate (DMAD) has been used 
in the synthesis of medium size ring carbocycles and heterocycles. 
The cycloaddition of DMAD to cyclic enamines forms a fused cyclobutene 
system, which may undergo step-wise thermal ring expansion to yield 
the corresponding ring diene. 
To synthesise 1-benzazocines, quinoline derivatives (61-63) were 
used as the cyclic enamines.
43-45 
The construction of the 
1-benzazocines involved formation of an intermediate which underwent 
thermal electrocyclic ring opening. The cyclo-addition and ring 
expansion" of cyclic enamines (61,62) (Table 4) is shown in Scheme 4. 
Scheme 4 
17 
Table 4  
A(ii)-(1) 1-Benzazocines  
Ring enlargement by cleavage of an internal bond  
Starting materials Reaction conditions Product(s) Yield 
% 
Ref. 
- 
s 
N 
R 110 111111 11110 N 
N ' ■i 
(35) R=R 1 =H NaI04 in CH3OH/H20 (47) R=R1 =H - 27-30 
(35) Pt0 /CH-CO C H /0 
2 J 	2 2 5 2 (47) - 29 
(35) (i) CHC1 3 -C2H5OH/H 0 (47) HC1 salt - 31 
(ii) KOH A 
(36) R=6-isopropyl 148) R=8-isopropyl - 30 
(37) R=6-0CH 2C 6H 5 (49) R=8-0CH 2 C6H 5 - 30 
(38) R=5-C 6H 5 
NaI04 in 
(50) R=7-C6H 5 - 30 
(39) R=6-C6H5 
CH3OH-H 20 
(51) R=8-C6H 5 - 30 
(40) R=7-C6H 5 (52) R=9-C 6H 5 - 30 
(41) R=6-C 2H 5 (53) R=8-C 2H 5 - 32 
(42)[
R=6-C1 
1 CHCOOH/03 
R=8-C1, 
- 33 
R =CH2 CONH2 
3 1 R=CH 2CONH2 
- 
18 
Table 4 continued 
(43 
CH3 0 
CH3 
(44) 
(45) 
(46) 
1 =CH ilR 
1110 
R 
R1 =CH3 , 
R1 =R=H 
(45) 
(45) 
R=OCOCH3 
R1 =H II 
R=6,7,8-(OCH3 ) 2 
2C6H 5 
Ri 
hv-(200 w) 
halogen lamp, 
02' CH3OH, CH 2C1 2 
25° 
C6H6/BrCN/N2 
CH3 COON/(CH3C0) 20 
ethyl chloroformate/ 
Na 2CO3 
(i 	) 	trifluoro- 
acetic anhydride/ 
(ii 	) hydrolysis and 
(iii) oxidation 
(rr " 
CH30 
CH3 
(56) 
(57) 
(58) 
(59) 
3 CH 
(60) 
R=8,9,10- (OCH3 ) 3 
R1 =CH2 C 
. 
lilt 
R 	R1 
CH3 H 
H 	H 
=R1  =H 0 
R2=4rH u 
R3 =COCH 
R3=CO 
11110 
R=OCOCH 1 R =COCF3 
6 H5 
R 	R1 	. 
82 
, 
43 
,40 
- 
- 
- 
, . 
34 
38-40 
38 
41,42 
41 
42 
R=R1=H,R2=C1 
N 
13 R 
R2 	R3 
Br 	CN 
Br 	CN 
u  3 
3 
2 
2 C2H 5 
N 
R=H 
11 R 
3 
(69) 
19 
Apart from this method, highly reactive and easily generated 
benzazetes were used to synthesise 1-benzazocines. 46 '47 The 
benzazete (69) also formed an initial adduct (70) with cyclopentadiene-
ones, which underwent cleavage of the N-C6 bond to form the 
corresponding'l-benzazocine derivative (71) (Scheme 5). 
 
-CO 
  
  
Scheme 5 
The strain in the initial adduct (70) was relieved by the extrusion of 
carbon monoxide.
46 
When cyclopentadiene (72) was reacted with 
2-phenyl benzazete (69) it only gave an amino alcohol (74). In this 
case, the strain in the intermediate (73) was less than that in (68), 
and the amino alcohol (74) did not undergo further ring enlargement. 
(Scheme 6). Unlike cyclobutadiene, 2-phenylbenzazete does not react 
with DMAD, but does give conjugated addition products resulting from 
nucleophilic attack.
43 
(69) 4- 
 
H20 
  
(72) 
	
(73) (74) 
Scheme 6 
20 
The synthesis of 1-benzazocines by addition followed by ring 
enlargement is given in Table 5. 
Table 5  
A(iii)-(1) 1-Benzazocines  
Addition followed by ring enlargement  
Starting material Reaction conditions Product(s) Yield % Ref. 
(63) 
111111  
11110 
1111° 
(61) 
(62) 
N 1 
N 1 CH 
CH 3 
3 
CH-C-NR2 
S 11 
(i)DMAD 	• 
CHiCN/N2 
(ii)dry C6H6 
reflux 
DMAD in 
dioxane 
DMAD in 
dry C6H6 
reflux 
. 
CH 3  
11110 
(65) 
(66)R 
(67)R2 
111111 
(68) 
0 
0 
CO 
02 
2CH3 
2CH3 
CH3 
CH3 
3 02CH2, 
78 
55 
40 
45 
58 
43 
44 
44 
44 
45 
z 
N I 
(64) 
NR2 1 CH-C=S 
1111111 
\ 
N I CH3 
R2 = 	4(--)0 
	
= N4 	) 2 	\ 
= 	N 
CO 
/.."'■ 
CH 4 N 
., 
N' 1 CH3 
N 8 
CO CH 
3 
_ 	(76) CO2 CH3 ■•111 
CO2CH3 
CO2CH 
(77) 
1 
21 
Table 5 continued 
(69) + 
C6H 5/ 
C6H5 ......y)t...,....„"C6H5 
0 
1 	1 
■ 
'C6H5 
• 
CH2C1 2 
-78° 
(71) 52 
52 
46 
47 
A(iii)-(2) 2-Benzazocines  
The cyclo-adduct (76), which was obtained by the reaction of (75) 
with dimethylacetylenedicarboxylate, underwent -a novel rearrangement 
giving rise to 2-benzazocine (77).48 The proposed electrocyclic 
reaction was given in Scheme 7. 
Scheme 7 
NCCH3 ) 2 
N(CH3)2 
(82) 
(83) 
(79) ---> 
(85) 
22 
A(iii)-(3) 3-Benzazocines  
In the presence of boron trifluoride, the acetylene derivative 
(79) and 3,4-dihydroisoquinoline (78) gave the intermediate (80), 
which afforded the 3-benzazocine (81) in 75% yield. If water was 
added to the reaction mixture, the formation of lactam (82) was 
observed.
49 
(78) 
C6H 5-C=C-N(CH3 ) 2 
(79) 
However the reaction of isoquinoline (83) and (79) gave 3-dimethylamino-
2-phenylnaphthalene (85) as the only isolable product.
49 
A possible 
pathway for this reaction is shown in Scheme 8. 
Scheme 8 
23 
Treatment of 6,7-dimethoxy-1,4,5,9b-tetrahydro-2H-azeto[2-10- 
isoquinoline (86) with 15% hydrochloric acid afforded the 
tetrahydrobenzazocine derivative (87).
50 
CH 3O CH 3O 
CH3 	 CH 0 
(86) (87) 
A(iv) Other ring enlargements  
A(iv) 1-Benzazocines 
A paper by Ross and Proctor
51 
described the synthesis of 
1-benzazocines from the 1-benzazepine derivatives. This ring expansion 
was achieved in two ways. First the treatment of the dibromocyclopropane 
derivative (88) with ethanolic silver nitrate solution gave the 
benzazocine (89) in 50% yield. A higher yield (81%) of benzazocine 
(90) was obtained by the ring expansion of (88) in pyridine and water. 
With anhydrous pyridine, the yield of (90) was only 14%. This implies 
the assistance of water in the transfer of a proton from the intermediate 
alkyl cation to the base, pyridine. 
Hydrolysis of (90) gave a 78% yield of 5-bromo-2,3-dihydro-1-2 .- 
tolylsulphony1-1-benzazocine (89). 
Br 
N N N 
12 
12 12 R R R 
(88) R 1 =0C2H 5 (89) 
R
2 
= tosyl group 
(90) 
0 
N :NH 
/". 
2 > 
CH CH 
3 3 
(91) 
24 
• A(iv)-(2) 2-Benzazocines  
Ring expansion of the 1,1-dimethy1-2-phenylpyrrolidinium ion (91) 
in the presence of sodium amide in liquid ammonia afforded the tertiary 
amine (92) and a polymeric material in yields of 41 and 38% respectively. 52 
The benzazocine (92) was a product of ortho substitution and 
rearrangement involving the expansion of a five-membered ring to an 
eight-membered ring. The polymeric material formed through the 
8-elimination reaction of the quaternary ammonium ion (91). It has 
been found that the rearrangement of six-membered quaternary ammonium 
ion (93) occurred exclusively to form the corresponding nine-membered 
ring product. Hence the conformation of quaternary ammonium ion (91) 
appears to be less favourable for the rearrangement than that of (93).
52 
The structure of (92) was established by Hofmann degradation and 
spectral data. 
(B) Ring closure  
B(i) C-C type  
The synthesis of benzazocine derivatives has been achieved by ring 
closure with the formation of a C-C bond, of the types A to E, as 
shown in the Figure 4. 
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(A) (B) 
	
(C) 
(D) 
Figure 4 
Ring closures of type A to D were employed-to synthesise 1-benzazocines 
by Dieckmann cyclization of the appropriate esters. Ring closure of 
type E were used to synthesise 3-benzazocines by the Friedel -Crafts 
reaction and the intramolecular cyclizations with polyphosphoric acid. 
No synthesis of 2-benzazocines by C-C ring closure has been reported. 
B(i)a Dieckmann cyclization  
B(i)a-(1) 1-Benzazocines  
The direct cyclization of amino ester (94), in the presence of 
potassium tert -butoxide
53-55 
or sodium in liquid ammonia
56 
 gave 25% to 
75% of (95) together with two other benzazocines (96,97), in trace 
amounts. 
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CH3 
	 CH3 
(94) (95) R=R 1 =H 
(96) R=CO2CH3 , R1 =H 
(97) R=H, R1 =CO2C H 
2 5 - 
The 1-benzazocine-6(5H)-one derivative (100) was obtained by the 
cyclization of (98) with (99) in anhydrous dimethylformamide containing 
sodium hydride.
57 
 
CO2CH3 
. Br-(CH 2 )4 -0O2C2H 5 
(99) 
 
(98) 
N-H 
RI 
 
R = tosyl 
Attempts to prepare tetrahydro-1-benzazocine-5(6H)-ones (95), from 
diesters of type (94) with sodium hydride were unsuccessful because of 
the base catalysed elimination of the tosyl group.
57 
This elimination 
was seen to operate only between carbon-nitrogen atoms already joined 
by a 6-bond. Suitable model compounds were prepared to explore this 
possibility. Thus the ester (101) and ketone (102) were treated with 
27 
various bases and in every case, the starting material was recovered. 
CO C H 2 2 5 
H ) 
CO2
C
2
H
5 
(1 01 ) 
	
(102) 
R = tosyf 
Several other derivatives were prepared from these benzazocines. 
In a series of patents, Okamato and co-workers 66-7° reported the 
conversion of 1,2,3,4-tetrahydro-l-benzazocine (103) into the 
N-substituted derivative (104), but the synthesis of (103) was not 
given. 
58-65 
 
(103)R=H, X=H or Cl 
(104)R=COCH:CHC6H 5' X=H or Cl 
 
B(i)b Friedel-Crafts reaction 
B(i)b-(1) 3-Benzazocines  
The Friedel-Crafts reaction of various substituted glycyl 
chlorides (105-107, 111) has been employed to prepare 3-benzazocine 
derivatives. 	The cyclization occurred smoothly and in fair yields 
in the presence of anhydrous aluminium chloride at room temperature. 71-75 
At higher temperatures the recorded yields were poor and at -10° no 
reaction was observed. 74,75 Comer and co-workers73 found that the 
CH 0 
N-R NH 
CH3 / 0 Cu 
R-C-C6H5 
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prolonged reaction of glycyl chlorides with excess aluminium chloride 
resulted in the selective cleavage of the 9-methoxy group. Therefore 
the formation of the final product mainly depends upon the temperature 
of the reaction. 
The 3-benzazocines obtained by the intramolecular Friedel -Crafts 
reaction are summarized in Table 6. 
B(i)c Other C-C type ring closures  
B(i)c-(1) 3 Benzazocines  
This method is closely related to the Friedel -Crafts cyclization 
of glycyl chlorides, but the cyclohydration was carried out in the 
presence of polyphosphoric acid (PPA) instead of aluminium chloride. 
The general reaction is given in Scheme 9. 
(A) 
	
(B) 
	
(125) R=H 
(126) R=CH 3 , C6H5 
Scheme 9 C6H4' Cl -p or C 6H4CH3 -p 
In the presence of phosphorus oxychloride, the amide (125) did not 
undergo the expected cyclodehydration giving rise . to a heterocyclic 
ring system. However, the polyphosphoric acid, the compound (125) did 
yield the 3-benzazocine derivative (128) (Table 6) in 25% yield. 91 
In the case of amides of type (126), (R/H), the cyclodehydration with 
phosphorus oxychloride resulted in the formation of the corresponding 
1-styry1-3,4-dihydroisoquinoline derivatives. 91 Unlike aluminium 
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Table 6  
B( i )b-(1 ) 3-Benzazocines  
Friedel -Crafts reaction  
Starting material s reaction conditions Products Yield % Ref . 
(105) 
(106) 
(107) 
(108) 
(109) 
(110)1 
11110
1110 
R1 
R1 
R3 
Al C1 3 in CH2 C1 2 
Al C1 3 
Al C1 3 
A1 C1 3 
Al C1 3 
Al Cl 3 
(115) 
(116) 
(117) 
(118) 
(119), 
(120) 
11110 / 	
N—R3 
j 
1 
R1 =R2=R3=H 
R3=S02C6H 5 
R3 =S02CH3 
R1 =R2=OCH3' R4 =H 
R3 =COC6H5 
-R1 =R2=OCH 3 ' R4 =H 
R3 =SO2 C6H 5 
{ 	
=COC 
= 2=OCH3 , R4 =CH3 
1 
R' 	H5 6 
- 
75 
- 
- 
- 
- 
71,72 
71,72 
71,72 
67 
73 
73 
111 =R2=R3=H 
R3=502C6H5 
R3 =502CH3 
. 
Cl 
R3=COC 
R1 =R 
R3 =S0 
=R2=OCH3 ' 4 R=H 
6H5 
2=OCH3' R4 =H 
2C6H5 
=R2=OCH3 ' R4 =cu " 3 
=COC6H 5 
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Table 6 continued 
CH 
CH 
1110 
110 
___ 
3O 
3O 
Cl. 
• 	N-S02 -C6H, A1C1 3-CH2C1 2 15° to room 
°temperature  
AlC1 3 room temperature 
BF /H 2SO4 
BF3/H2SO4 
CH 3O 
CH30 
(123) R=C0C6H5 
11110 
o 
- 02C6H5 36 
50 
- 
- 
74 
75 
76 
76 
(111) 
1110 
(121) 
NH 
(122) 
H 
40 
(113) 
(114) 
+ 	- tilH2 	Br 
/ (CH 2 ) 3 Br 
(112) 
CH3 
1110 	• 
CH3 
R=C0C6H5 
R.CH 2C6H5 (124) R=CH 2C6H5 
H 	CH3 
The hexahydro-3-benzazocine (122) was converted into several N-substituted 
derivatives by alkylation.
77-88 
chloride, polyphosphoric acid does not cleave the aromatic methoxy group. 
Therefore the latter is a better dehydrating agent than the former and 
this ring closure reaction is more satisfactory as a preparative method. 
Other C-C type ring closures employed to synthesise 3-benzazocines 
are given in Table 7. 
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Table 7  
B(i)c-(1) 3-Benzazocines  
Other C-C type ring closures  
Starting materials reaction 
conditions 
Product Yield 
% 
Ref. 
CH 3O 
CH3 1 
(108) 
(109) 
(110) 
CH3 6 
CH 3O 
(126,127) 
R3 
R 1 =C0C6H 5 , 
R 1 =S02C6H 5 , 
R 1 =COC 
1110 
1110 
1110 
6H 
=H 
(114) 
(114) 
(125) 
C6H5 
R2=R3=H 
5' R
2=CH 
u 
CH-C 
R2=R3= 
N41 
N-R1 
3' 
o 
NH 
PPA/75° 
PPA 
80% H SO4 
PPA/ 
120°-130° 
15 minutes 
H 0 
CH 3 I 
(118) 
(119) 
(120) 
H 0 
H 0 
(129,130) 
110 
SI 
R1 =COC 
lip 
(128) 
CAH 
3 
NH 
79 
85 
76 
- 
- 
25 
73 
73 
73 
89 
90 
91 
R1 =C0C6H5 , 
R
1
=S02C6H 5 , 
‘ 
R2=H 
R2 =H 
6H 5' R
2=CH
(124) 
(124) 
NH 
6 5 
\ 
5 	i 
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Table 7 continued 
(126) R=H CH3COON and (129) R=H - 92 
H 2SO4 
(127) R=CH3 SnC1 4 (130) R=CH3 - 93,94 
B(ii) C-N type 
Ring closure with the formation of a C-N bond, of the types A to D. 
(Figure 5) has been employed to synthesise derivatives of all three 
benzazocines. 
(A) (B) 
	
(c1 
	
(D) 
Figure 5 
B(ii)-(1) 1-Benzazocines  
The construction of eight-membered rings by the formation of a C-N 
bond has been mainly employed to synthesise the eight-membered quinones 
(132,135) rather than the 1-benzazocines. These compounds were 
prepared by the intramolecular Michael reaction of primary amines 
(131,134). 95-101 The Michael reaction on the aziridine (134) gave a 
small amount of the eight-membered quinone (135), together with 
another product.
98 
This latter major product was likely to be 
formed by the interaction of the aziridine nitrogen atom with carbonyl 
group. 
CH3 
0, 
02/CH3OH CH 
3O
 
H3 	CH30 
[H] 
---> 
CH3 
OCH 
CH3 
CH3 
OR H2 
(131) R=CH 2C6H5 
CH3 
OR 
OH 
Cbz 
(133) (132) 
(134) (135) 
R4 _1 
OH 
R 1 =CH 2OH 
R2=R3=OCH 3 
R4=H or CH3 
Cbz=carbobenzoxyl 
CH30 
CH3 
(136) 	Cbz 
C 6H 5Li Cl (CH ) NHCH3 
 
(137) 
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Recently, a paper by Yoshito
101 
described the conversion of the 
quinone moiety of (132) and of (135) into the corresponding 
hydroquinones (133,136). This was achieved by reduction, and 
N-carbobenzoxylation followed by acid hydrolysis resulted in the 
formation of 1-carbobenoxy1-8-methoxy-9-methyl-1,2,3,4,5,6-hexahydro-
1-benzazocine-5(6H)-one in high yield. These eight-membered quinones 
were prepared as precursors in the synthesis of mitomycins, which are 
a class of antibiotics with activity against Gram-positive and Gram-
negative bacteria and also against several kinds of tumors. 
The hexahydro-l-benzazocine (138) was prepared by the cyclization 
of (137) in the presence of phenyl lithium in ether. 15 
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B(ii)-(2) Bis-l-Benzazocines  
In a series of patents, Jonsson and co-workers
102 
 reported 
the preparation of the bis-l-benzazocine (140) by the intramolecular 
cyclization of the amine (139). The experimental details and yields 
of the products were not reported. 
 
(139) 
B(ii)-(3) 2-Benzazocines  
0401 
Several 2-benzazocines (142-146) were prepared by the condensation 
of 1-chloro-4-(2-chloromethylphenyl)butane (141) with an appropriate 
amine in the presence of sodium carbonate
6 
or lithium bromide.
105 
(Table 8). 
CH2Cl 
RNH2 
(CH ) C1 
 
 
(141) 
	
(142-146) (Table 8) 
The compound (147) (Table 8) was prepared by the cyclization of 
(149) with phosphorus pentachloride or aluminium chloride.
103 
NH 2 
( H 2 ) 3 
Cl (149) 
35 
Table 8  
B(ii)-(3) 2-Benzazocines  
(C-N ring closure) 
Product R Yield 
% 
Reference 
(142) -(CH2 ) 3N(CH3 ) 2 24 105 
(143) -CH2CHCH3CH 2N(CH3 ) 2 22 105 
I 
(144) -CH2 ) 2-N-CH2-CH(OH)-CH -CH2 8 105 
(145) -(CH ) OH 
2 2 , 
- 6 
(146) -(CH2
)C1 80 6 
(147) H - 106 
(148) , COH or COCH3 
- 107 
Hassner and Amit
107 
reported on conformational studies of (148). 
B(ii)-(4) 3-Benzazocines  
The synthesis of 3-benzazocines by the ring closure of C-N type 
can be further divided into two groups. These are 
(a) ring closure by condensation, and 
(b) reductive ring closure. 
B(ii)-4a Ring closure by condensation  
The condensation of o-substituted amines (150-153) in tetralin
108 
or xylol
109 gave the corresponding 3-benzazocines (154-157) in 55% to 
98% yields. 
0 
NR-.R 
CH30 
,/,.///1\ ,/) 
(153) 
xylol 
(157 ) 
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tetralin - H3 NH-CH, 
C=0 \ OH 
(150) R 1 = R2 = H (154) 
(151) R1 = R2 = OCH 3 (155) 
(152) Rl + R2 = OCH 3 (156) 
R = CH 2C 6H 5 
B(ii)-4b Reductive ring closure  
The reductive ring closure of nitriles takes place in the 
presence of a suitable catalyst such as Raney nickel or Raney cobalt 
or palladium on charcoal in methanol.
110-113 	
The reduction of the 
dinitrile (158) with Raney cobalt, which is considered to be a mild 
catalyst, gave the 3-benzazocine (163) together with amines (159) and 
(160). The yields of these by-products were increased by addition 
of small amounts of water to the reaction mixture. When Raney 
nickel was used, the addition of water greatly influenced the yield 
of (163).
110 	
However addition of more water decreased the yield of 
(163). The best yield of (163) was obtained by the reaction carried 
out in methanol containing acetic acid. In this case acetic acid 
depressed the formation of by-products. 
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RO RO 
(158) 
(159) 
R=R3=CH3 , R 1 =R2=CN 
R=R3=CH3 , R 1 =CH2NH2 , 
R2=CN 
{ 
(163) R=R3=CH3 , R2 =H 
(164) R=H, R2=R3 =CH 3 
(165) R=CH 3 , R2=R3=C 2H 5 
(166) R=R3=CH3 , R2=CH 2C6H 5 114 
(160) R=R3=CH3 , R 1 =R2=CH 2NH 2 
(161) RH, R 1 =R2=CN, R3 =CH3 
(162) R=H, R 1 =CN, R2=CH 2 NH2' R3 =CH3 
(167) R=CH3' R2=R3=H 115,116 
(168) R=R2 =R3=H 
The conditions used in this reductive ring closure are summarized 
in Table 9. 
(C) Photocyclization  
C(i)-(1) 1-Benzazocines  
In recent years, photochemical reactions of N-aryl enamino ketones, 
examined by Yamada and co-workers,
117-120 
have opened a new route for 
the synthesis of 1-benzazocines. These workers have studied both 
N-substituted and N-unsubstituted aryl enamines to investigate the 
possibilities in the preparation of benzazocines. 
On irradiation with a pyrex-jacketed immersion lamp, the 
N-substituted enamino ketone (169) gave a carbazole (176) instead of 
the anticipated eight-membered ring product. Under the same 
conditions, the N-unsubstituted enamino ketones (170-175) gave the 
1-benzazocine derivatives (177-182) together with a ketene adduct and 
a lactone.
117 	
In this case no corresponding carbazole was detected. 
OH 
1110 	41111 CH R 3 CH3 
(177-182) 
R1 	R2 R3  
(177) H 	H CH3 (178) 7-C1 	H CH3 
(179) 8-0CH3 H CH3 
(180) 7-0CH3 H CH3 (181) 'HHH 
(182) H 	H H 
(176) CH1 
R3 
'4 	R3 
(169-175) 
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Table 9  
B(ii)-4b 3-Benzazocines  
Reductive ring closure  
Starting material Reaction conditions Product Yield % Ref. _* (158) (a) Ra-Co/CH30H-H 2 100 0  
high pressure autoclave 
(163) small 
amount 
110,111 
(b) W-2 Ri-Ni/CH30H-H 2 (163).HC1 21 110,111 
high pressure autoclave salt 
(c) W-2 Ri-Ni/CH30H TH2 (163) 65 110,111 
CH3COOH-high pressure autoclave 	. 
(d) W-2 Ri-Ni 42 110,111 
(160) Pd-C/H2 	or (163) 78 110 Pd/BaSO4 in xylene 
(161), 	(162) R5-Ni/H2 (164) 92 112 (162) R5-Ni/H20 (164) 113 
* _ Ra-Ni = Raney Nickel 
R1 R2 R3 R4 
(169) H 	H cH 	CH 3 3 (170) H 	H cH3 H (171)3'-C1 	H cH3 H (172)4 1 -0CH3 H cH 3 H 
(173)3'-OCH3 H cH3 H 
(174) H 	H . H 	H 
(175) H 	cH3 H 	H 
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However the yields of 1-benzazocines obtained by photocyclization was 
poor (between 3%-20%) when compared with the other methods. 
In order to investigate the mechanism of these photochemical 
reactions, the irradiation of enamino ketones was carried out with a 
low pressure mercury lamp, and no eight-membered ring product was 
isolated. When a high pressure mercury lamp was used, the formation 
of benzazocines were observed.
117 
These results indicate that the 
* 
excited state in this photoreaction is the n4T triplet. 
The benzazocine derivative (182) was synthesised from the 
corresponding ketone (175) using a high pressure mercury 1amp. 119-120 
Kinetic studies involving potentially aromatic dihydrobenzazocine 
anions have been reported by Johnson.
121 
C(2) 2-Benzazocines  
The ketone (183) underwent a novel rearrangement on irradiation 
giving rise to the 2-benzazocine (185) in 93% yield. Action of heat 
on (173) in toluene also resulted in the formation of (185). 122 	On 
further irradiation, the benzazocine (185) gave a mixture of ring 
contracted products. 
C H 1 6 11 
0 CH3 
(183) R2=0, R=CO2 CH3 or H 
(184) R2=N-C 6H 11 , R=C02CH3 or H 
C(3) 3-Benzazocines  
C6H5•0 CH 3 
1 1 
(185) R2=0, R=CO2 CH3 or H 
(186) R2=N-C,H.... [KO CH or H b II' 	2 3 
Photochemical ring closure of N-(chloroacetyl)phenylpropylamine 
40 
derivatives (187-190) resulted in the formation of 3-benzazocines 
(191-194) in 25%-30% yield. 123-126 	Irradiation of (188) with a low 
pressure mercury lamp gave the benzazocine (192) along with a dimeric 
product having the molecular formula C22H2020 4 . 123  The related 
3-benzazocine (192) was prepared in 30% yield using a high pressure 
mercury immersion lamp. 124 	In this case no dimeric products were 
detected. 
(187)R1 =R2=R3=H 
(188)R1 =H, R2=0H, R3=CH3 
(189)R1 =R3=H, R2=OCH3 
(190) 2 R1 = - = - K uCH3' R3 =H  
(191)R1 =R2=R3=H 
(192)R1 =H, R2=0H, R3 =CH3 
(193)R1 =R3=H, R2=OCH3 
(194)R1 =R2=OCH3 , R3=H 
1,5] [1,3] 
	
[1,4] 
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Chapter 3  
Benzodiazocines  
The number of possible isomers for the benzodiazocine system 
is nine, and seven of them are known (Figure 6). 
[2,3] [2,5] [3,4] 
Figure 6 
As with the benzazocines, the methods employed for the synthesis 
of benzodiazocines are (A) ring enlargements, (B) ring closures and 
(C) photochemical reactions. In addition to these methods, 1,5- 
benzodiazocines were prepared from bridge-head compounds by the 
cleavage of an endo-methano bridge. 
Methods of Preparation  
(A) Ring enlargements  
The ring enlargement reactions can be further divided into four 
sub-divisions and these are, 
) rearrangements - Schmidt reaction, 
(ii ) ring enlargement of benzodiazepines and indole derivatives, 
42 
(iii) addition followed by ring enlargement and, 
(iv ) ring enlargement by cleavage of an internal C-N bond. 
A(i) Rearrangements  
The Beckmann rearrangement of benzo fused ketones has not been 
employed to synthesise benzodiazocine derivatives. The only 
rearrangement reaction used is the Schmidt reaction. The reported 
yields of the Schmidt reaction were very poor and the formation of 
by-products was observed. Hence this has not been used as a major 
preparative method. 
A(i) a Schmidt reaction  
A(i) a-(1) 1,5- and 1,6-benzodiazocines  
Misiti et a124 reported that the Schmidt rearrangement of 
1,2,3,4-tetrahydro-l-benzazepine-5-one (195) gave only 2% of 
2,3,4,5-tetrahydro-1N-1,5-benzodiazocine-6-one (197) and 6% of 
4,5,6,7-tetrahydrotetrazolo45,1-4-1,6-benzodiazocine (198). The 
major product (83%) was a benzimidazole (199), which was formed by 
aryl migration (Scheme 11). The N-tosyl derivative (196) also gave 
a similar result showing that aryl migration is prodominant in this 
rearrangement. 2" 27 
Scheme 11 
(195) R = H 
(1 96) R = tosyl 
(201) 
C l 
(200) 
NH.CH3 
Cl 
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A(ii) a Ring enlargement of benzodiazepines  
A(ii) a-(1) 1,5-benzodiazocines  
The ring expansion of the benzodiazepine (200) to the benzodiazocine 
(201) was achieved by treatment with 10% aqueous sodium hydroxide at 
room temperature.
' 28,129 
R = 2-furyl 
A(ii) b Ring enlargement of indoles  
• Both 1,5- and 1,4-benzodiazocines have been synthesised by the 
ring enlargement of indole derivatives. 
A(ii) b (1) 1,5-Benzodiazocines  
Sodium periodate oxidation of the indole derivative (202) 
followed by a series of reductions gave 6-pheny1-1,2,3,4,5,6-hexahydro-
1,5-benzodiazocine (203).
130 	
(Scheme 12). The related indole (204) 
oxidised with chromic trioxide gave the 8-chloro-3,4-dihydro-l-methy1- 
6-phenyl-1,5-benzodiazocine-2-(1H)-one (205).
131,132 	
Sharbatyan and 
co-workers 133 have reported on the mass spectral behaviour of (205). 
A(ii) b-(2) 1,4-Benzodiazocines  
Hydrogenolysis of the azido compound (206) gave the aminoacetyl-
oxindole (207). Then continuous extraction of(207) with aqueous 
sodium bicarbonate solution resulted in the formation of the dione 
Cl 
( 205 ) 
CH3 N3 
44 
CH3 
(CH 2 ) 3NH 2 
(202) ( 203 ) 
5 --* ---> 
C l 
(204) 
Scheme 12 
derivative (208). 134 	(Scheme 13). 
	
H 2 	
Pd-C, HC14 
60° 	 0J% C104 
CH 2 -NH3 
(206) 
	
(207) 
   
1 
    
   
  
MOO 
    
Scheme 13 
Cl A 
hv 
Cl 
(210) 
CH3 
CH3 
(212) (209) 
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A(iii) Addition followed by ring enlargement  
A(iii) (1) 1,6-Benzodiazocines  
The cyclobutene adduct (211) was readily obtained by the reaction 
of N,N-dimethyl-o-phenylenediamine (209) and cis-3,4-dichlorocyclo-
butene (210) in the presence of n-butyl lithium. The gas phase 
thermolysis of (211) at 285° gave the 1,6-benzodiazocine (212) as the 
only detectable product; this ring expansion was reversed on 
irradiation. 135 
A(iii)-(2) 2,3-Benzodiazocines  
The cycloaddition of dimethylacetylenedicarboxylate (DMAD) to 
1-oxido-3-phenylphthalazinium (213) in chloroform under reflux gave 
the 2,3-benzodiazocine derivative (214).
136137 
Replacing 
chloroform with , xylene afforded only the cycloadduct (215). However 
the reaction of (213) with phenylacetylene in xylene gave the ring 
expanded product (217). It has been suggested that both (214) and 
(217) are formed by the electrocyclic reaction of the normal 
cycloadducts (215 and 216) respectively. (Figure 7). 
The catalytic hydrogenation of (217) with 10% palladium-charcoal 
gave the tetrahydro derivative (218) in 80% yield. 137 Harlow and 
Simonsen
138 
have reported the X-ray crystal structure of (218). 
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N 
 
15i) 
DMAO 
	
de N— CHC1 3 > \ 
C6H 5 
(213) 
6H 5ECH 
xylene 
C6H 5 
N,
,N 
(217) 
(214) 
02CH3 
CO2CH3 
(215)X = Y = CO 2CH3 
(216)X = C 6H 5 , Y = H 
Figure 7 
A(iii)-(3) 2,5-Benzodiazocines  
The reaction of 3-dimethylamino-2,2-dimethyl-211-azirine (219) 
and phthalimide in dimethylformamide gave the ring expanded product, 
4-dimethylamino-3,3-dimethy1-1,2,3,6-tetrahydro-2,5-benzodiazocine-1,6- 
dione (220). 139 A suggested pathway for the formation of (220) is 
given in the Scheme 14. 
H3 
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(219) 
CH 
NL3-
CH3 
CH3 
CH3 
(220) 
Scheme 14 
A(iv) Ring enlargement by cleavage of an internal C-N bond  
This method has been employed to synthesise 1,6- and 2,5- 
benzodiazocine derivatives. 
A(iv)-(1) 1,6-Benzodiazocines  
The tetrahydropyrrolo[1,2-a]benzimidazoles (221,222) underwent 
benzylation at the bridge-head nitrogen to give the quaternary 
ammonium ion (223). (Scheme 15). Treatment of (223) with aqueous 
solutions of sodium hydroxide, sodium tetrahydroborate or sodium 
cyanide in the cold, resulted in the cleavage of the C-N bond between 
the quaternized nitrogen atom and the adjacent carbon atom-0 5 , giving 
rise to an eight-membered ring product (224).
140,141 	
The reaction of 
sodium hydroxide with (221) gave a tautomeric mixture of ring expanded 
product (224) and a ring opened product (225) in equal yields. 
Nu 
Nu 
N-CH R 
2  C6H C N-CH 2R 
(223) (224) 
R=C6H 5' 4.NO2 .06H4 
HCH2C6H 5 
I- 
(224) 
(R.C6H 5 
(221)R=C6H 5 
(222)R=4.NO 2 -C6H 
1,, Le H 
' NH C=0 Nu=0H, H, CN 
48 
(225) 
Scheme 15 
A(iv)-(2) 2,5-Benzodiazocines  
In a series of patents, Sulkowski et al142-148 and Winn149 '150 
described the ring expansion of 9-(4-chloropheny1)-1,2,3-9b-tetrahydro-
5N-imidazo[2,1-a]-isoindo1-5-one (226) to the 2,5-benzodiazocine 
derivative (227), in moderate yield. Unlike 1-benzazocines, the 
cleavage of the internal C-N bond was achieved by reduction with 
lithium aluminium hydride in anhydrous ether. Similarly, 
benzodiazocines (228-232) were prepared from the corresponding 
imidazoisoindolones.
146,147,151 
This type of reduction can only be applied to the N-unsubstituted 
imidazoisoindolones, with N-substituted derivatives, lithium aluminium 
hydride reduction caused the cleavage of the N-1/C-9b bond and no eight-
membered ring products were obtained.
142 
Instead the unstable 
isoindoles were formed.
151 
49 
R 1 
(226) 4-C106H4 (227) 4-C1-C6H4 
(228) 2,4-(OCH3 ) 2 •C6H3 
(229) 3,4-Cl•C 6H3 
(230) 4-0CH 3 -C6H4 
(231) C6H 5 
(232) CH3 
The 2,5-benzodiazocine (227) was converted into various N-substituted 
derivatives 152 ' 154 and oxidation of (227) resulted in the formation 
of tricyclic imidazoisoindoles.
155-160 	
The pharmacological studies 
161,164 
of (227) also were carried out by several workers. The 
benzadiazocine (227) was found to be an effective anorexic agent 
and caused primary depression of cardiovascular function.
162,163 
(B) Ring closure  
B(i) C-C type  
The Bischler-Napieralski reaction is the only method employed 
to synthesise 1,5- and 2,5-benzodiazocines by ring closure of the C-C 
type. This is a widely used method for the synthesis of 1,5-benzo- 
diazocines. 
B(i)a Bischler-Napieralski reaction  
B(i) a-(1) 1,5-Benzodiazocines  
The cyclodehydration of amide (233) was carried out in the presence 
50 
of phosphorus oxychloride under reflux to give the corresponding 
•,5-benzodiazocines,
165-170 
but the yields were not reported. 
CH CH3 
1 3 1 
(233) (234 ) 
R = H, Cl 0 
R 1 = OH, CH3 C-0, OCH2-C6H 5' C6H 5' Cl 
R
2 
= C6H 5' 2-C1•C6H4' 2'-F-C 6H4 
B(i)-(2) 2,5-Benzodiazocines  
De Martino et a1
171 
reported the synthesis of 6,11-dihydropyrrolo-
[1,2-b][2,5]benzodiazocines (238-240), containing a new heterocyclic 
system, from 1-(2-acetylaminomethylbenzyl) pyrroles (235-237). The 
ring closure of (235) and (236) in phosphorus oxychloride proceeded 
smoothly and in high yields to give the corresponding benzodiazocines 
(238,239). The lactam (241) was prepared by the intramolecular 
cyclization of (237) with zinc chloride.
171 
B(ii) C-N type  
The C-N type of ring closure is the most widely used preparative 
method in the construction of benzodiazocine derivatives. Out of 
the nine possible isomers for the benzodiazocines, six isomers (A-F) 
51 
(235) 
(236) 
(237) 
COCH3 
COC6H 5 
CO2 C2H 5 
(238) 
(239) 
(240) 
CH3 
C6H 5 
H 
(241)  
(Figure 8) have been prepared by this method. The formation of the 
carbon-nitrogen bond was achieved by intramolecular cyclizations and 
condensation reactions. 
1,3 1,4 1,5 
(A) (B) 
	
(C) 
1,6 2,5 3,4 
(D) (E) (F) 
Figure 8 
N-R 
(252) R=CH3 
(253) R=S02 -C6H 5 
5 0 
NH 
52 
B(ii)-(1) 1,3-Benzodiazocines  
The condensation of amines (242-245) with COC1 2 or CS2 
afforded the corresponding 1,3-benzodiazocine derivatives (246-250) in 
fair yields.
172,173 
R
1 
R
2 
R
3 
(242) (CH2 ) 3 (246) 0 H H 
(243) (CH2 ) 2CHCH3 (247) S H H 
(244) CH 2 -CH.CHICI-CH3 (248) S CN3 H 
(245) (CH2 ) 2CH-C 6H 5 (249) S CH3 CH3 
(250) S C6H 5 H 
B(ii)-(2) 1 ,4-Benzodiazocines 
The 1,4-benzodiazocines (252,253) were prepared by the 
intramolecular cyclization of N-2-(2-aminophenyl)ethylglycine (251) in 
acetonitrile. The cyclization was induced by the use of dicyclo- 
hexylcarbodiimide (DCC); this reaction did not proceed in Ryridine. 174 
No explanation is available for the influence of the solvent in the 
above cyclization. However this ring closure method was reported by 
the same author to be more versatile than the previously described 
method
134 (p. 43) for the synthesis of 1,4-derivatives. 
COCH
3 (254) 
53 
The lactam (252) was readily reduced to the corresponding diamine, 
but no basic product was obtained from (253), under the same 
conditions. 
The 1,4-benzodiazocine-5-one (254) was synthesised in 94% yield 
by the condensation of 13-(N-phenylacetamide)ethanamide, in a mixture of 
sulfuric and acetic acids.
175 
B(ii)-(3) 1,5-Benzodiazocines  
Synthesis of 1,5-benzodiazocines by the formation of a C-N bond 
has been used extensively
176-192 
and they consist of ring closures 
of type A to E. (Figure 9). 
(A) (B ) 
(D ) 	 CE) 
Figure 9 
The starting materials and the reaction conditions employed for 
the synthesis of 1,5-benzodiazocines by the C-N ring closure reactions 
are summarized in Table 10. 
Bagataskii and co-workers
198 
have reported the synthesis of a 
triazolo derivative of 8-chloro-6-phenyl-3,4-dihydro-1,5-benzodiazocine 
by the ring closure of the corresponding benzophenone derivative. 
The corresponding tetrahydro-1,5-benzodiazocine-2-(1H)-one was obtained 
54 
Table 10  
B(ii)-(3) 1,5-Benzodiazocines  
(C-N type ring closure) 
Starting materials Reaction conditions Products Yield 
% 
Reference 
(255) 
(255) 
(257) 
Cl 
(259) 
(261) 
(261) 
(cb5) 
(265) 
,..../ 
R
" 
(266) 
(263) 
ilk 
40  
I 
NH-R2 
R1 =C1, R2=H 
R1 =Br, R2=H 
CH 
j3 
N-(CH 2 ) 3 C1 
S1 0 
R
1 R2 
1 0 
N-C-(CH 2 ) NH 2 
R=C1, 111 =R2=H 
R=C1, R1 =0-1 3 , 
2
=H ti 2 
R=C1, R1 =C1-1 3 
R
2
=0 
NH— CH3 
CU 
I 1 -- N-CH2-CHR 
R=NO
2' R 1 =H 
(i ) CI(CH2 ) 2C0C1/ 
(ii) NH3 
condensation with an 
amino acid 
Cl(CH2 ) 2C0C1 and NH 3 
KI/C
2
H
5
OH/NH3 under 
pressure 
POC1 3/pyridine 
pyridine/A 
0 
pyridine/HC1 
toluene/A 
dry HCl/C5H5 
(256) 
(256) and 
(258) 
(260) 
(262) R=C1, 
(262) 
 
(264) fR=C1, 
1 
(205) 
(205) 
(267) 
(, R 
derivatives 
-- I/ 
R=C1R2 =0, 
R
1
=R
i
=H 
several other 
R=Br, R1 =R3 =H, 
R2=0 
fRc1, R1=CH3 , 
R =2H, R
3
=H 
R1 =R2=R3=H 
R 1 =C1-1 8 , 
= ? =R3 H 
=C1, R 1 =CH,, 
2 , J 
R =0, re=H 
. 
R=NO 2 , R1=CH8, 
=NH, R3=H 
51 
45 
74 
40 
_ 
_ 
23 
- 
176,177 
178 
179 
176,177 
180 
180 
180,181 
180 
182 
180 - 
183 
• 
55 
Table 10 continued 
 
(268) R=C1, R 1 =H 
(270) R=CF3 , R 1 =H 
(272) R=C1, R1=CH3 
(274) R=CF3 , R1=CH3 
NH 2 
111111 --'N -CH-CH-CN 
* R2R1 
(276) Ri + R7 =H 
(278) R5=C1 
(280) R
5
=CH3 
(282) R
5
=CF3 
'  
(284) R
5 
 =NO2 
(286) R
5
=OCH3 
(288) R5=R7=C1 
(290) R
5
=C1, R7=OCH3 
(292) R4=R5=0CH3 
(294) R3=OCH3 , R5=C1 
(296) R 1 =CH3 , R5=C1 
(298) R
2
=CH3 , R
5
=C1 
(300) R
2
=CH3 , R5=R7=C1 
(302) R 1 =CH3 , R5=R7=C1 
(304) R2=CH
3,
R4=R5=OCH
3 
(°5) R 1 =CH3 , R4 =R 5 =OCH3 
(308) R
5
=R
2
=CH3 
(310) R
1
=R
5
=CH3 
(312) R1 =CH3' R
5
=R
6
=C1 
NH 2 
11110 
dry HC1/C5H6 
" 
. 
. 
CH3OH dry HC1 room 
temperature 
. 
is 
. 
is 
. 
. 
. 
II 
is 
. 
. 
. 
. 
. 
. 
- 
(269) 
(271) 
(273) 
(275) 
R 
lilt 
(R 1 -R7 
 
starting 
(277) * 
(279) 
(281) 
(283) 
(285) 
(287) 
(239) 
(291) 
(293) 
(295) 
(297) 
(299) 
(301) 
(303) 
(305) 
(307) 
(309) 
(311) 
(31 3) 
1110 
(315,317,319) 
2 
R 
3 
as 
* 
R=C1, 
R2=NH, 
R=CF3, 
L.RNH, 
R=C1 
R:CF,, 
R4=NH, 
R 1  = CH3, 
R3=H 
R 1  =CH3 , 
R3=H 
R1 =CH 
' , 3' 
=NH, RJ=CH
3 
R1  =CH,, , 3 , 
R =CH3 
H2 
Ni 
— 
el 
R7 
with the 
material) 
H  
N 
N 
I 
- 
- 
- 
_ 
60 
85 
70 
74 
46 
47 
38 
60 
77 
74 
86 
66 
25  
82 
32 
53 
40 
69 
29 
183 
183 
183 
183 
184 
. 
is 
. 
. 
. 
II 
II 
II 
is 
is 
II 
" 
. 
ii 
. 
" 
is 
N-(CH)C1 23 
I 
R 
(314,316,318) 
* . 
These 2-amino-3,4-dihydro-1,5-benzodiazocines were converted into many other derivatives.
.193-197 
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Table 10 (continued 
(314) 
(316) 
(318) 
(320) 
(322) 
(324) 
(326) 
(328) 
Is = 
11110 
(330) 
R=CH 2C5H5 
R=CO5 
0 
R=H, 
R=H, 
.7...i./, 
1 .,, 
. 
tosyl 
WC 
R=4-CH3.C5H002 
N —4( 
NHR 1 
i 
R1 =C5H5 
R1=CH2C5H5 
CO2CH3 
. 
I 
CH3 
R 
—(CH2)3C1 
NHCH 
(CH2)2C1 
CH3 
H 
K2CO3/DMF/A 
. 
n 
dioxane/(C 2H 5 ) 3/A 
n 
CH3 /NH2/A 
, 
THF/diborane 
BuOH/Na 
A 
condensation 
• 
331) 
(315) R=CH
(317) R=C 
111111 
(325) R=R1 =CH
(327) 
el 
(319) 4-CH 3 •C5H•02 
(321) R 1 C6H5 , 
(323) R1 =CH2 C5H5 , 
(329) R=R1 =tosy1 
2-C 6H 
6H 5 
N 
1 R1 
• 
3 
R 
7 
R 1 
R=4-C1C5H5 
1 
R =CH3 
C5H5 
I 
N 
( 
5 
R=H 
R=H 
• 
, 
cH3 
\ 
H 
CH 3 
64 . 
29 
70 
77 
- 
185 
185 
185 
186 
187 
188 
189 
190 
191 
192 
R=4-C1C 5H5 
3 e 
NHTs Br 
+ 
NHTs 
S 
6H 5 C = 
+ 
_.._. 
H 
When not specified R n =H. (n=1,2,3....) 
57 
by the reduction of the dihydro derivative. 198 The hexahydro 
derivative of (306) was converted into the pyrido[3,2-1-kl]-1,5-benzo-
diazocine derivative by cyclization with 0-propio1actone. 199 
B(ii)-(4) 1,6-Benzodiazocines  
Several 1,6-benzodiazocines were prepared in moderate yields by 
the condensation of o-phenylenediamine derivatives (322) with 
1,4-dibromobutane in butanol.
200-203 
 
R
1 
NHR Br 
N 
NHR Br 
(332) (333) R=R1=(CH3)3.C6H2-S022 00 
(334) R=R=CH3 .C6H4
201 
(335) R=R1 =u3 202,203 
(336) R=H, R1 = c05202,204 
The condensation of o-phenylenediamine (322, R=H) with 
1,2-dibenzoylethane resulted in the formation of 2,5-dipheny1-1,6- 
dihydro-1,6-benzodiazocine (337) and a seven-membered ring product 
(338), 205 but not the earlier reported 208 2,5-dipheny1-1,6-benzodiazocine 
(339). However the yield of (337) was only 7%, and (338) was the 
major product. 
CH 
/65 
  
  
 
C 6H 5 
(337) (338) (339) 
58 
The reaction of (332, R=H) and diethyl succinate in a solution of 
dimethylformamide containing sodium hydride afforded the 3,4-dihydro-
1,6-benzodiazocine-2,5-(1H,611)-dione (340) in 8% yield.
207,208 
(340) 
The parent ring system, 1,6-benzodiazocine, having molecular 
formula 
C10H8N2' 
appears in the Ring Index,
209 
but further details 
could not be obtained. 
B(ii)-(5) 2,5-Benzodiazocines  
Sulkowski and co-workers
148,210,211 
described the synthesis of 
(343,344) by the cyclodehydration of (341,342) in the presence of 
pyridine. The early work carried out by the same authors 148 
reported that the cyclodehydration was effected by refluxing (341) 
in pyridine containing a catalytic amount of pyridine hydrochloride. 
In the absence of the catalyst, only starting material was recovered. 
I , 
NJ\CH 2 )iNH2 
(341) R = S02
C
6
H
5 
(343) 
(342) R = S02' C6H4
CH
3 
(344) 
 H Br Cl CH3 .•■■ 
N--(CH
3
)
2
NH
2 
CH
2
Br CH
3 Cl 
Cl 
Cl 
Cl 
(345) (346) 
N 
B P 
CH
3
/-N
CH 
3 
(347) 
NH2 \ 
NH
2
/ 
59 
The 2,5-benzodiazocinium bromide (347) was prepared in high yield 
by the condensation of (345) and 2-dimethylaminoethylamine (346) in 
hydrobromic acid.
212,213 
C l 	 C l 
The dione derivative (350) was also prepared in 32% yield by the 
condensation of (348) and ethylenediamine (349)• 214 
(348) R = Cl (349) (350) 
(351) R = C6H 5 
Attempts to synthesise (350) from 2-aminoethylphthalimide were 
unsuccessful because of competing inter- and intramolecular 
reactions.
215,216 
The condensation of (351) with (349) resulted in the formation 
of a lactam (352).
217 
Several other 2,5-benzodiaZocines (353-369) 
were reported similarly.
217 
(Table 11). 
The hexahydro derivatives (370,371) also appear to have been 
60 
Table 11 
B(ii)-(5) 2,5-Benzodiazocines  
(C-N type ring closure) 
R
2 
0 
(352-369) 
Compound number R1 R
2 
R
3 
R
4 
R
5 
(352) H H H H C6H5 
(353) H C2H 5 
H H C6H 5 
(354) H H H H 4-C1 C
6
H
4 
(355) H C
2
H
5 
H H 4-C1 C
6
H
4 
(356) H H H H 4-0CH
3 
C
6
H
4 
(357) H H CH 3 
CH
3 
C
6
H
5 
(358) H H CH3 H C6
H 5 
(359) H H H H CH2
-C
6
H
5 
(360) H H CH3 
H 4-C1 C
6
H
4 
(361) NO2 
H H H C6
H
5 
(362) H H H H 2-thienyl 
(363) H H CH3 
CH
3 
2-thienyl 
(364) H H H H 4-F-C6
H
4 
(365) H H OH OH 4-0H C6
H
4 
(366) H H H H 4,3-C1(NH 2 )C 6H3 
(367) H H H CH3 4-C1 C 6
H
4 
(368) H CH
3 
H H 4,3-C1(NH2 )C6H3 
(369) H CH
3 
H H 4-C1 C
6
H
4 
0 
(372) R = C 6H 5 (375) 
(373) R = 2,4-xyly1 (376) 
(374) R = H (377) 
(378) 
61 
prepared by the condensation of (349) with the corresponding ortho-
substituted benzene derivative.
218 
(370) R = H 
(371) R = tosyl 
B(ii)-(6) 3,4-Benzodiazocines  
The reaction of the diketone (372) and hydrazine hydrobromide in 
dimethylformamide, under high dilution conditions, afforded a low 
yield of 2,5-dipheny1-1,6-dihydro-3,4-benzodiazocine (375)•219 
Similarly (376) and (377) were prepared from the corresponding diketone. 
Attempted isomerization of (375) into (378), using 5% palladium on 
charcoal was unsuccessful 
219 
The novel Spiro derivative (379) was synthesised by the reaction 
of o-benzenediacetylchloride and 3,3-pentamethylenediaziridine in 
220 
anhydrous ether. 
NCO CH
3 
02 CH3 
hv 
02 
1;1 CO
2
CH
3 
COCH
3 
62 
(379) 
(C) Photochemical preparations  
Photochemical reactions have not been widely used for the 
synthesis of benzodiazocine derivatives. One isomer of 1,3- 
benzodiazocine and two isomers of 1,5-benzodiazocine were prepared by 
photochemical methods. 
C-(1) 1,3-Benzodiazocines  
The photooxygenation of (380) in methanol gave the eight-membered 
ring dione (381).
221 
(380) 
	
( 381) 
C-(2) 1,5-Benzodiazocines  
Irradiation of (382,383) in tetrahydrofuran, for one hour, 
resulted 222 ' 223 in the formation of 1,5-benzodiazocines (384,385) in 
70% yield in each case. 
63 
CH 
CH3 
hv 
0--N N/ 
1 
CH
3 
CH
3 
H3 
	
(382) 
	
(384) 
( 383) 
	
(385) 
N '1 
 
C
6
H
5 
(388)Z = 0 
(389)Z = H2 
(387) 
C l 
C l 
one (389). 
CO H 
(386) 
R = C
6
H
5' X = Cl 
R = 4.CH3'
C
6
H4' X = H 
CD) Synthesis of benzodiazocines from bridge-head compounds  
This method was used to synthesise derivatives of 1,5-benzo-
diazocines alone. 
(D)-(1) 1,5-Benzodiazocines  
Denzer and 
Ott224-226 
reported a novel route for the preparation 
of 1,5-benzodiazocines, by bridging the two nitrogen atoms of 
tetrahydroquinazoline (386) to form the 1,5-ftlethano derivative (387). 
Then (387) was reacted with hydrochloric acid in dioxan and water to 
yield (388) in 89% yield. On the other hand hydrogenolysis of the 
bridge-head lactam (387) with platinum in glacial acetic acid afforded 
8-chloro-5-methy1-6-pheny1-3,4,5,6-tetrahydro-1,5-benzodiazocine-2(1H)- 
64 
Ferretti and co-workers
227 
have discussed the aromaticity of 
dihydro-1,6-, -2,5- and-3,4-benzodiazocines 
[1,4] 
A 
[2,4] 
[1,5] 
[2,5] 
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Chapter 4  
Benzoxazocines  
Out of the fifteen possible isomers of benzoxazocine ring systems, 
only seven (A-G) have been synthesised so far. (Figure 10). 
Figure 10 
The preparative methods employed to construct these eight-
membered rings are (A) ring enlargements and (B) ring closure 
reactions. Unlike the situation with benzazocines and 
benzodiazocines, photochemical reactions have not been employed to 
synthesise benzoxazocines. 
Methods of Preparation  
(A) Ring enlargements  
The Beckmann and the Schmidt rearrangements have been employed 
to synthesise 1,5- and 1,6-benzoxazocines, while a 2,4-benzoxazocine 
was synthesised by the ring expansion of an isoquinoline derivative. 
The applications of these rearrangements are few and the Beckmann 
and the Schmidt reaction always gave mixtures of 1,5- and 1,6-isomers. 
66 
A( i) Rearrangements  
A(i) (a) Beckmann rearrangement  
A(i)a-(1) 1,5-Benzoxazocines  
Beckmann rearrangement of the benzoxepine oximes (390aA) gave 
a mixture of 1,5- and 1,6-benzoxazocines (391,392) due to concurrent 
alkyl and aryl migrations respectively. Attempted rearrangement of 
(3900 was not successful, and it was found that both electronic and 
steric factors were operative in this rearrangement.
228 
The 
rearrangement of (390e) with phosphorus pentachloride in a mixture of 
benzene and ether yielded only a small amount of the lactam (391e).
229 
The yield of (391e) and the formation of isomers were not reported. 
(390) N-OH 
(a), H (a), H (392a)Z=0 
(b), 8-CH 3 (b), 9-CH 3 (393) 2=2H 
(c), 6,8-(CH 3 ) 2 (c), 7,9-(CH3 ) 2 
(d), 7,8-(CH 3 ) 2 (d), 8,9-(CH3 ) 2 - 
(e), 8-C1 (e), 9-C1 
(f), 7-CH3 (f), 8-CH3 
A(i)a-(2) 1 ,6-Benzoxazocines  
The 1 ,6-benzoxazocine (392c) was obtained in 66% yield by the 
Beckmann rearrangement of (390c).
230 	The formation of the 1,5-isomer 
was not reported. 
0 
(394) 
a. R = H 
b. R = 8-C1 
 (392a) 
migration 
NaN3  
H2SO4 
CH3CO2H 
aryl 
9 
OC-CH3 
(397) 
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A(b) Schmidt reaction  
A(b)-(i) 1,6- and 1,5-Benzoxazocines  
When 2,4-dihydro-l-benzoxepin-5(2H)one (394a) was subjected to the 
Schmidt reaction in concentrated sulfuric acid and sodium azide in 
glacial acetic acid, a mixture of 3,4-dihydro-2H-1,6-benzoxazocine-5- 
(6H)one (392a, 54%), 4,5-dihydro-6H-tetrazolo[5,1-e]-1,6-benzoxazocine 
(395, 4%), 2-(3-acetoxy-propyl)benzoxazole L397,:13%) and 2,3,4,5-tetrahydro-
1,5-benzoxazocine (391a, 5%) were obtained. 24,231 
	
The 1,6-benzoxazocine 
derivatives and compound (397) were formed by aryl migration, while the 
1,5-benzoxazocine was formed by alkyl migration (Scheme 16); a subsequent 
ring contraction is also involved in the case of (397). 
alkyl 
  (391a) 
migration 
(395) R = H 
Scheme 16 (396) R = Cl 
It has been reported that the Schmidt reaction on (394h) only 
gave the tetrazole derivative (396) in 23% yield. 229 
In five and six-membered fused ring ketones the alkyl migration 
is predominant and it is influenced by the electronic effects of the 
hetero atom ortho to the carbonyl group. These effects do not 
operate in the seven-membered cyclic ketones because of the 
CH3 
CP (CH3CO2)0 e„ 'In CH3 COONa 
NO2 	CH30  NO2 
CH 3O 
CH3 0 
0 
HCCH3 
(400) 
0 
-C -CH3 
NO2 
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A(ii) Ring enlargement of six-membered rings  
A(ii)-(1) 2,4-Benzoxazocines  
The acetylation of 3,4-dihydro-6,7-dimethoxy-1-(2-nitrobenzy1)- 
isoguinoline hydrochloride (398) with acetic anhydride and sodium 
acetate afforded the 2,4-benzoxazocine (399) together with two other 
products (400 and 401). 234 The reported yield of (399) was 60% and 
it was found to be the cis-isomer, on the basis of the spectroscopic 
data and the chemical analysis. 	A mechanism for this interesting 
ring expansion was not given. 
(398) (399) 
CH3 
CH30 
0011 
The action of 98-100% formic acid and formamide on (399) gave 
the compound (402). 
CH30 
CH 30 
68 
flexibility of the ring. Therefore the aryl migration products 
are formed in an increased ratio.
24 
It has been found by the same 
workers, that the eight-membered cyclic ketones undergo only aryl 
migration. 
Kawamoto and co-workers
231 
have reported the formation of 1,6- 
and 1,5-isomers in a ratio of 7:3 when the ketone (394a) was treated 
with trichloroacetic acid and sodium azide. The mechanism proposed 
is illustrated in Scheme 17. 
H 20 
(391a) 
H 20 
(392a) 
(394) 
Scheme 17 
A paper by Tandon and co-workers
232 
described the synthesis of 
(392f) and (392d) by the Beckmann rearrangement of the corresponding 
ketones. However An this case, the formation of the 1,5-isomer was 
not reported. The reduction of these lactams resulted in the 
formation of the amines (393d and 393f), while the oximes (390b) and 
(390c), afforded (393 and 393) respectively, along with the 5-amino-
benzoxazepine derivative in equal yields.
232 
The compound (393f) 
was converted into various N-substituted derivatives.
233 
70 
(B) Ring closures  
Derivatives of 1,5-, 2,5-, 2,6-, 3,1-, and 1,4-benzoxazocines 
have been synthesised by ring closure of the C-0 and C-N type. The 
synthesis of benzoxazocines by ring closure of the C-C type has not 
been reported to date. 
B-(i) Ring closure of C-0 type  
Ring closures of the types A to E shown in Figure 9 have been 
employed to construct the 1,5-, 2,5-, 2,6-, 3,1- and 1,4-benzoxazocines. 
(A) (B) 
(E ) 
Figure 9 
B(i)-(1) 1 ,4-Benzoxazocines  
The treatment of (403) with sodium hydride afforded the 
1,4-benzoxazocine (404). The yield of (404) was not reported. 235 
(403) (404) 
0 
NO
2 --- N 1/ 
(408) 
H CH(CH3 ) 2 
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B(i)-(2) 1,5-Benzoxazocines  
The cyclization of the compound (405) with sodium carbonate gave 
the lactam (406), which on reduction afforded the tertiary amine 
(407).
236 
Cl C l 
( 405 ) 
	
(406) Z = 0 
(407) Z = 2H 
In a patent by Bodanszky, 237 the synthesis of 8-nitro-3,4-dihydro-
3- ( 2-methylpropy1)-2H-1,5-benzoxazocine-2-one (408) was reported, 
although no experimental details were given. 
0 
B(i)-(3) 2,5-Benzoxazocines  
The ring closure of (409) with potassium-t-butoxide in 
dimethylsulfoxide gave the lactam (411), which afforded 5-methyl-
1-pheny1-1,3,4,6-tetrahydro-2,5-benzoxazocine (412) on lithium 
aluminium hydride reduction.
238 	
Apart from this method, the compound 
(412) could be prepared directly by the ring closure of (410) with 
p-toluenesulfonic acid in xylene,
238 
or in benzene
239 
or with 
aqueous hydrobromic acid in chloroform.
240
'
241 	
The yield of (412) 
N--C—CHn C1 II 
I  
CH3 
Z 
(409)Z=0 
(410)Z=2H 
72 
was 81% and 95% respectively. The 2,5-benzoxazocines (413-417) were 
prepared similarly.
238 
(411)Z=0, R 1 =CH3 , R2=H 
(412)Z=2H, R 1 =CH3 , R2=H 
(413)Z=2H, R 1 =CH3' R2=4-C1 
(414)Z=2H, R 1 =CH3 .HC1, R2=5-C1 
(415)Z=2H, R 1 =CH3 , R2=2-CH3 
(416)Z=2H, R 1 =CH3 .HC1, R2=5-0CH 3 
(417)Z=2H, R 1 =C 2H5 •11C1, R2=H 
(418)Z=2H, R i = R2=H, R2 =H 
(419) Z=2H, R i =(CH 2 ) 3NH2 , R2=H 
The cyclization of 0-benzylbenzoyl chloride with 2-(dimethylamino) 
ethanol followed by reduction also afforded the 2,5-benzoxazocine 
(412).
242 	
The hydrochloride salt of (412) is known as Nefopam, which 
is being used as a pain-relieving agent.
246-266 	
A number of metabolic 
and analytical studies on Nefopam have been reported.
243-245 
The action of acrylonitrile on (418) followed by reduction with 
5% palladium on carbon, afforded the 5-(3-aminopropy1)-derivative (419) 
which was a central nervous system depressant. 267 
	
The synthesis of 
(418) was not given in the patent. 
The 2,6-dione derivative (421) was prepared in 77% yield by the 
action of 15% potassium bromide and hydrochloric acid on 2-bromo-
ethylphthalimide.
268,269 	
It has been found that nucleophilic 
73 
displacement of the bromo group by the carboxyl oxygen could yield 
(421), while (420) could be obtained by a displacement involving the 
amide oxygen.
268 
The isomer (420) can be rearranged into (421). 
0 
 
(420) (421) 
B(i)-(4) 2,6-Benzoxazocines  
The sodium tetrahydroborate reduction of 2-(3-chloropropiamido)5- 
chlorobenzophenone (422) in methanol gave an intermediate which 
afforded the lactam (423) on treatment with sodium in methanol.
270 
The yield of (423) and the structure of the intermediate were not 
given in the patent. 
Cl COC
6
H
5 
NHC-CH 9 -CH 9-C1 " 
.0 
(422) 
Cl 
 
(423) 
The cyclization of (420a,b) in the presence of potassium acetate 
in acetic anhydride gave the 2,6-benzoxazocine-1,3-dione derivatives 
(425a,b) as intermediates, which underwent ring contraction to form 
quinoline derivatives.271 
H -CH 2-CHR 1 -0H 
• NEC o 
(426) a, R 1 = CH 3 
b, R 1 = C2 H 5 
74 
OH 
H-CH2 -CH2-CO2H 
(424) 	
a, R = H 
(425) 
b, R = Cl 
B(i)-(5) 3,1-Benzoxazocines  
Ito et a272 reported the formation of 4H-5,6-dihydro-4-methy1- 
3,1-benzoxazocine (427a) and 4-ethyl-3,1-benzoxazocine (427b) in low 
to moderate yields by the intramolecular cyclization of isonitriles 
(426a,b) respectively in the presence of copper oxide. 
B(ii) Ring closure C-N type  
(427)11 1. = CH3 
(428)R 1 = CH 2 CH3 
The 1,5- and 1,4-benzoxazocines have been synthesised by the 
formation of a C-N bond, and the types of C-N bond construction are 
given in Figure 11. 
(A) (B) 
	 Cc) 
Figure 11 
0- CH 2 - CH2 -N(CH 3 ) 2 
CH 2 -CH3 
( 4 29) 
NaOH 
NH 
N/ 
NHCH 2 -C6H 5 
Br 
+ NEC-CH-CH2 Br 
NH 
NH-CH2 C6H 5 
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B(ii)-(1) 1 A-Benzoxazocines  
The reaction of o-(2-dimethylaminoethoxy)propiophenone (429) with 
bromine followed by treatment with 20% sodium hydroxide in the cold 
resulted in the 1,4-benzoxazocine derivative (430). 273 
B(ii)-(2) 1,5-Benzoxazocines  
The condensation of 2,3-dibromopropionitrile and (431) gave 
2-imino-5-benzylamino-5,6-dihydro-1,5-benzoxazocine (432) in 32% 
yield. 274 
(43 1) 
	
(432) 
A series of 1,5-benzoxazocines'were prepared by the treatment of 
an appropriate 0-acetylphenoxy propane epoxide (433) with ammonia in 
anhydrous methanol at room temperature.
275 	
The cyclization proceeded 
slowly through the formation of an intermediate amino alcohol (434). 
Attempts made to accelerate this process resulted in decreased yields. 
The 1,5-benzoxazocines obtained by this method are given in Table 13. 
Pharmacological studies of (435) have been reported by Caputi and 
76 
Table 13  
B(ii)-(2) 1,5-Benzoxazocines  
(C-N type ring closure) 
Compound No. R'  Other substituents Yield % 
(435) CH3 - 
38 
(436) C2H 5 
- 23 
(437) n-C3H 7 
- 8 
. 	(438) i-C3H 7 - 
5 
(439) t-C4 H 9 
- 
• 
2 
(440) C6H 5 - 12 
(441) 4-CH3 C6H4 - 
5 
(442) CH 2 -C6H 5 
- 6 
(443) (CH2 ) 2 -C6H 5 - 7 
(444) CH=CH-C 6H 5 - - 
(445) 4-NO2 •C6H4 -CH=CH - 
- 
(446) 2-C 5H4 0 
5 
(447) CH3 3-CH3 
19 
(448) CH3 
8-C1 6 
(449) CH 3 
8-C6H 5 4 
(450) CH3 
8-NO2 - 
(451) CH3 
9-C6H 5 15 
(452) CH3 
8-nC 3 H 7 CONN 58 
(453) CH3 7,9-C1 2 
8 
(454) CH3 8,10-C1 2 
12 
(455) CH 3 8,10-(CH3 ) 2 
4 
(456) CH 3 9,10-C6H2 34 
(457) CH3 5,6-H 2 - 
77 
( 433) (434) 
co-workers.
276 
OH 
CH—CH2NH 2 
(435-457) 
B(ii)-(3) 1,6-Benzoxazocines  
A dimeric product (458) of 1,6-benzoxazocine was obtained by the 
reaction of 4-hydroxy-3-aminobenzenearsonic acid with an equal 
quantity of succinic anhydride. 278 
0 H 
0 
(458) 
Orlova and co-workers
278 
 reported the alkylation of the 
1,6-benzoxazocine (459). 
78 
Chapter 5  
Dibenzazocines  
Examples of all six possible isomers of dibenzazocines have been 
synthesised and the skeleton of each isomer is illustrated in 
Figure 12. 
PA 
A 
[c,e] [beg] 
[b,e] [b,f] 
Figure 12 
Derivatives of [c,e] and [b,f1 dibenzazocines have been prepared 
in a larger number than the other isomers. 
The synthetic methods employed to construct these tricyclic 
systems are similar to those for benzazocine derivatives, i.e. 
(A) ring enlargements 
(B) ring closures 
(C) photochemical preparations and 
(D) from bridge-head compounds. 
79 
The types of ring enlargements used are, 
(i ) rearrangements 
(ii) ring enlargement followed by cleavage of an internal 
bond and, 
(iii) addition followed by ring enlargement. 
As with the benzo analogues, the rearrangements employed are the 
Beckmann and the Schmidt reactions. The Beckmann rearrangement of 
tricyclic ketones is one of the most widely used methods while the 
application of the Schmidt reaction is limited to one case. 
Methods of preparation  
(A) Ring enlargements 
(A)i Rearrangements 
A(i)a Schmidt reaction  
A(i)a-(1) Dibenz[c,e]azocines  
The reaction of tricyclic ketone (460) with sodium azide in 
trichloroacetic acid gave the ring expanded lactam, 5,6,7,8-tetrahydro-
dibenz[c,e]azocine-6-one (463) in 60% yield.
279,280 	
The formation 
of by-products were not reported. The reduction of (463) with lithium 
aluminium hydride afforded the tertiary amine (464).
281 
(460) Z = 0, R = H (463) Z = 0, R = H 
(461) Z = NOH, R = H (464) Z = 2H, R = H 
(462) Z = NOH, R = OCH3 
(468) (469) (470) (467) 
80 
A(i)b Beckmann rearrangement  
A(i)b-(1) Dibenz[c,e]azocines  
The Beckmann rearrangement of the oxime (461) in pyridine and 
benzenesulfonyl chloride yielded 67% of (463).
282 
However the 
rearrangement of the substituted oxime (462) with phosphorus 
pentachloride in anhydrous benzene, proceeded with difficulty, giving 
rise to the lactam (465) in poor yield (10-40%).
283 
The major product 
was a nitrile (466) which was formed by the attack of chloride ion on 
the strained ring system. (Figure 13). 
CH2 Cl 
CH2 CN 
 
R C1(;) 
Figure 13 
(465) 
R = OCH3 
(466) 
The treatment of polyphosphoric acid (PPA) at 100 0 , on the mono-
oximes of (467) and (468) gave 7-pheny1-5,6,7,8-tetrahydrodibenz[c,e]- 
azocine-5,8-dione (469) and 5,6,7,8-tetrahydrodibenz[c,e]azocine-5,7,8- 
trione (470) respectively.
284 
81 
A( i )b- ( 2) Di benz [b ,f]azoc i nes  
In the presence of phosphorus pentachloride at room temperature, 
the oxime (471), underwent the Beckmann rearrangement giving rise to 
a 65-90% yield of lactam (472).
285-287 	
The reduction of (472) 
yielded the 5,6,11,12-tetrahydrodibenz[b,f]azocine (473) which was 
converted into various N-substituted derivatives. 288-298 
N-substituted derivatives of the lactam (472) have . also been 
prepared.
299-302 
011is and Stoddart
303 
have reported on conformational 
studies with the lactam (474). The lactam (476) was obtained in 90% 
yield by the Beckmann rearrangement of oxime (475) with polyphosphoric 
aciO
36,304-308 
Replacing polyphosphoric acid with thionyl chloride in benzene, 
the oxime (475) afforded the 6-chlorodibenz[b,f]azocine (478) in 90% 
yield.
309,310 	
The 6-methoxy derivative (479) was obtained by the 
reaction of (472) with trimethyloxonium fluoroborate followed by 
treatment with N-bromosuccinimide/benzoyl peroxide and then potassium- 
tert-butoxide.
3 	
The N-methyl derivative of (477) was prepared
311 
by 
methylation of (476) followed by reduction. 
N-OH 
(471) (472) Z = 0, R = H 
(473) Z = 2H, R = H 
(474) Z = 0, R = CH 2 C6H 5 
NOH 
(475) 
	
(476) Z = 0 (478) X = Cl 
(477) Z = 2H (479) X = OCH3 
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A(i)b-(3) Dibenz[b,e]azocines  
The treatment of (480) with phosphorus pentachloride in benzene 
gave the lactam (481), but the yield and any occurrence of side 
reactions were not reported.
312 	
However, with phosphorus trichloride, 
the oxime (480) afforded (481) in 59% yield. 313 
N-OH 
(480) 
A(i)b-(4) Dibenz[c,f3azocines  
The dibenz[c,f]azocine (483) was obtained from (482) via a 
lactone intermediate and subsequent reaction with ammonium hydroxide 
and ethanol.
314 
(482) 
A(i) Ring enlargement followed by cleavage of an internal bond  
A(ii)-(1) Dibenz[c,e]azocines  
The dibenz[c,e]azocine (485) was obtained by the reductive 
cleavage of the dienone (484) on hydrogenation over 10% palladium-
charcoal in ethanol.
315 	
The triacetate derivative (486) was obtained 
by a similar ring enlargement of (487) in the presence of 98% sulfuric 
CH30 
CH30 
(486) 
OR 
(485) R = H 
(486) R = COCH 3 
Scheme 18 
observed during the oxidation. 
I I I 
N 
(488) 
(490) 
83 
acid and acetic anhydrice.
309 
(Scheme 18). 
A(ii)-(2) Dibenz[b,e]azocines  
Periodic acid or sodium metaperiodate oxidation of (488) gave 
5,7-dihydrodibenz[b,dazocine-6,12-(6H)-dione (489) in 71% and 49% 
yields respectively.
316 
The formation of a dimer (490) was also 
84 
A(ii)-(3) Dibenz[b,f]azocines  
The oxidative cleavage of 10-(2-dimethylaminoethyl)-7-chloro-5,10- 
dihydroindeno[1,2-b]indole hydrochloride (491) with ozone in acetic 
acid gave 2-chloro-5-(3-dimethylaminopropy1)-5,6,11,12-tetrahydro-
dibenz[b,n-azocine-6,12-dione (492).  the diones 
(493-495) were prepared from the corresponding indeno[1,2-b]indole 
derivatives 
317,318 
Cl 
f l k CH 2 , 314,CH312 .HC1 
(491) 
Scheme 19 
(492) R = (CH 2 ) 3 N(CH 3 ) 2 , X = Cl 
(493) R = (CH2 ) 3N(CH3 ) 2 , X = Br 
(494) R = (CH2 ) 3 N(CH 3 ) 2 , X = H 
(495) R = X . 
H. 318 
The reduction and dehydration of (492) resulted in the formation of 
the 2-chloro-5(3-dimethylaminopropy1)- derivative of (477). 319 
Landquist and Sandstrom
320 
have investigated the barriers to ring 
inversion in the dibenzazocinone series. 
A(ii)-(4) Dibenz[b,g]azocines  
A large excess of sodium in liquid ammonia, caused the cleavage 
of the C10-C11 bond of (496) and (497) giving rise to 5,6,7,12- 
tetrahydrodibenz[b,Aazocine (498) in 50% yield.321 
101 
1 0 
(496) X = Cl 
(497) X = H 
85 
(498) 
A(iii) Addition followed by ring enlargement  
Only the dibenz[c,e]azocines have been prepared by this method, 
which has not been as widely used as the other preparative methods. 
A(iii)-(1) Dibenz[c,e]azocines  
The mono-vinyl azide (499), which was obtained by the reaction 
of 2,2'-divinylbiphenyl and iodine azide, gave the cyclo-adduct (500), 
when allowed to stand at 0' for three days; thermal rearrangement of 
(500) then afforded (501). Addition of hydrochloric acid to (501) 
gave the ring expanded dibenzazocine derivative (502) in 68% 
yield.
322,323 	
The cyclo-adduct (504) obtained by the thermolysis of 
divinyl azide (503) gave 8-azido-5-methyldibenz[c,e]azocine (505) 
when treated with acid.
322 
(Scheme 19). 
(B) Ring closure  
B(i) C-C type  
The methods employed for the synthesis of dibenzazocines by the 
formation of a C-C bond can be divided into three sub-divisions as, 
(a) Bischler-Napieralski type reactions, 
(b) Friedel-Crafts reaction and 
(c) Aryl-aryl coupling reactions. 
(499) (501) 
86 
(500) 
(502) 
HC1 
(503) (504) 
Scheme 19 
The applications of the Bischler-Napieralski and the 
(505) 
Friedel -Crafts intramolecular cyclizations are limited to two cases 
of dibenz[b,f]azocines. 
87 
B(i)a Bischler-Napieralski reaction  
B(i)a-(1) Dibenzjb,flazocines  
In the presence of polyphosphoric acid and phosphorus pentachloride, 
the amides (506) and (507) gave 6-methyl and 6-pheny1-11,12- 
dihydrodibenz[b,f]azocine (508) and (509) respectively. 324 
1110 
NH 
`C=0 
(506)R = CH 3 
(507)R = C6H 5 
(508)R = CH3 
(509)R = C 6H 5 
B(i)b Friedel-Crafts cyclization  
B(i)b-(l)Dibenz[b,f]azocines  
The intramolecular cyclization of the isocyanate (510) in the 
presence of aluminium chloride in o-dichlorobenzene gave the 
dibenz[b,flazocine-6-one (472) in high yield.
325
'
326 
(510) 
B(i)c Aryl-aryl coupling reactions  
This method has been employed to synthesise derivatives of 
[c,e], [b,g] and [b,d] dibenzazocines. 
88 
B(1)c-(1) Dibenz[c,e]azocines  
The electrolysis of compound (511) in a solution of 10% sodium 
perchlorate and acetonitrile containing anhydrous sodium carbonate 
gave the dibenz[c,e]azocine (514) in 60% yield, by aryl-aryl 
coupling.
327 
The electrolysis was conducted at a controlled anode 
potential of 1.15v. Similarly (515) was prepared from (512). The 
reported yield of (515) was 45%• 327 
The ring closure of (513) gave the dibenz[c,e]azocine (516). 328 
The Pschorr reaction of (517) afforded the lactam (519), 
whereas the analogue (518) afforded a triazinone; 329 inaccuracies 
exist in the abstract, however, and these results need to be 
investigated further. 
1 1 
(511)R1 =R2=OCH3 , R3=COCH3 , Z=2H (514) 
(512)R1 =R2=0CH3 , R3 =COCH3 , Z=0 (515) 
(513)R1 =OCH3'
2
=0H,
3
=SO
2
CH
3' 
Z=2H (516) 
CH-0 
(517)X = NH 2 , n = 2 (519) 
(518)X = NH2 , n = 1 
OH 
(521) 
B(ii) C-N type ring closure  
(522) 
89 
B(i)c-(2) Dibenz[b,g]azocines  
The phosphate of 1,3-bis(2-aminophenyl)propane (520) gave the 
dibenz[b,g]azocine (498) in 43% yield, when heated at 290-300° for 
90 minutes.
330-332 
(520) 
B(i)c 7(3) Dibenz[b,d]azocines  
The dibenz[b,d]azocine-6-one (522) was prepared in 41% yield 
by the aryl-aryl coupling.of (521) in the presence of 
trifluoromethanesulfonic acid (TFSA).
333 
Under the same reaction 
conditions, the seven-membered analogue was prepared in 76% yield. 
The C-N type of ring closure is a most widely used method for 
the synthesis of dibenz[c,e]and [c,fgazocines. The general 
types employed to construct a carbon-nitrogen bond are shown in 
Figure 14. 
(523) 
90 
+ :N 
(A ) 
	
(B) 
Figure 14 
B(ii)-(1) Dibenzjc,ejazocines  
Reaction of N-ethoxycarbony1-2-ethoxy-1,2-dihydroquinoline (EEDQ) 
with compound (523) directly afforded (524) which was isolated as 
the methyl ester (525) in 24% yield. 334 	It has been found that EEDQ 
can readily induce the formation of peptide linkages.
335 
EEDG.  
(524) R = CO2H 
(525) R = CO2 CH3 
Belleau and Schuber
336 
 reported the molecular rotation and 
conformational studies of (525). 
Several other dibenz[c,e]azocines were prepared by two different 
procedures: (i) intramolecular cyclization of the dibromide (C) with 
an amine,
279,237-242 
and (ii) intramolecular cyclization of the bromo-
amine (D) in the presence of a base.
342-345 	
It has been reported 
that the yield of cyclic amines obtained by procedure (i) was better 
CH2 —C---C 
I \cP 
NH3 
CH -CH -NH 2 2 2 (ii) 
H3OH/KOH 
H2Br (cyclic amine) 
H -CH 2-Br 
(1) 
RNH 2 in 
(D ) 
(C) 
91 
than that from procedure (ii) 279,337,338 (Scheme 20). 
Scheme 20 
The intramolecular cyclization of the dibromo compounds (543,545,547) 
with methylamine in methanol gave the cyclic amines (527,532,530, and 
526) respectively.
279
'
337-342 
The N-ethylated derivative (528) was 
obtained directly by the reaction of (543) with ethylamine in 
benzene.
339 
The compounds (526,532,533,535,537,538,540 and 542) were 
prepared from the bromo-amines (544,546,548-550 and 552-554) 
respectively, in the presence of methanolic potassium hydroxide. 343,346 
The reported yields of the cyclic amines were between 10-30%. 
In this case the N-ethylated derivatives (528,534,539 and 541) were 
formed as by-products of the cyclization of (544,548,553 and 554) 
respectively. Kotera and co-workers
346 
reported the conversion of 
(526) and (542) to their N-methylated derivatives. 
CH 0 
(530) R=H , R i =CH3 
( 531 ) R=OCH 3 , R1 =CH3 
(532) R=OCH 3 ' R1=H 
(526) R=H 
(527) R=CH3 
(528) R=C2H 5 
(529) R=CH 2C6H 5342 
' (533) R=H 
(534) R=C2H 5 
OCH3 
(537) R=H 
(540) R=H 
(541 ) R=C 2 H 5 
(538) R=H 
(539) R=C2H 5 
(535) R=H 
( 536) R=C2H 5 
CH ..0 
92 
(545) R1 =OCH3 , R2 =R3 =Br 
(546) R 1 0CH3 , R2 =NH 2 , R3 =Br 
(547) R i =H , R2=R3=Br 
.(( 542) R=H (543) Ri =R2=Br 
(544 ) 	=NH 2 , R2=Br 
93 
(555) 
(548) R1 =R2=0CH3 , R3=R4=R5=R6=H 
(549) R2=R3=OCH3 , R1 =114=R5=R6=H 
(550)111 =R2=R3=R4=H, R5=R6=OCH3 
(551) R2=OCH3 , R 1 =R3=R4=R5=R6=H 
(552)111 =R2=R3 =R4 =H, R4 =R5=OCH3 
(553) R1 ,R2=OCH 20, R3 =R4=R5=R6=H 
(554)111 =R2=R3=R4 =H, R5=R6=0-CH 2 0 
The condensation of (543) with piperidine gave the quaternary 
ammonium salt (555).
347 
The calculation of the enthalpy and entropy 
of activation and the Arrhenius parameters for this reaction were 
reported by Hall and Harris. 348 
337,338,349-356 
Many workers have reported the transformation of 
galanthamine (556) into 1,2-dihydroxy-6-methy1-5,6,7,8-tetrahydro-
dibenz[c,e]azocine (557), known as apogalanthamine. Galanthamine is 
an alkaloid, frequently encountered in the bulbs of plants of the 
Amaryllidaceae. The reaction of 48% hydrobromic acid and acetic 
acid
337,338,349,350 
or 20% hydrochloric acid
351-353 
and galanthamine 
(556) yielded 90% and 78% of hydrobromide and hydrochloride salt of 
(557). In order to establish the structure, (557) was further 
converted into the 1-hydroxy-2-methoxy- (558) and 1,2-dimethoxy (530) 
derivatives by methylation. 
94 
(556) (557) R=R1 =H 
(558) R=H, R 1 =CH3 
(559)
R=C6H5' 
R1=CH
3 
The reaction of (558) with bromobenzene in pyridine containing 
potassium carbonate and copper powder gave the 1-phenoxy-2-methoxy-6- 
methy1-5,6,7,8-tetrahydrodibenz[c,e]azocine (559). 357 
The mass spectral fragmentation
358 
and spectrophotometric 
determinations
359-361 
of (557), and (558), have also been reported. 
The compound (558) has been tested for antiarrhythmic
362-366 
and hypotensive
367-370 
activities. The effects of (558) on regional 
blood circulation,
371 
and other pharmacological activities of (558) 
have also been investigated.
372,373 
B(ii) - (2) Di benz[c,f]azocines  
Derivatives of dibenz[c,f]azocines have also been synthesised by 
the condensation of the dibromo compound (560) (page 96) with various 
amines. For example, the reaction of (560) with methylamine in 
anhydrous benzene under'reflux gave 5,6-dihydro-6-methy1-7H,12H-dibenz- 
[c,f]azocine (561) in 57-80% yield. 374-376 The 5,5,7,7-tetradeutero 
compound of (561) also was prepared in 97% yield. 374 '375 Similarly 
several other dibenz[c,f]azocines (562-575) were prepared in high 
yields. 
375-380 
(Table 14). 
95 
Table 14  
8001-Dibenz[c,f]azocines  
(2) C-N type ring closure  
Compound number X 
. 
R Yield 
% 
Reference 
(562) H C2H5 74 375 
(563) H n-C3 H7 54 
u 
(564) H i-C3 H7 86 
u 
(565) H CH 2=CH-CH 2 50 
u 
(566) H n-C4H 9 58 
u 
(567) H 1-methyl-3-piperidylethyl 78 u 
(568) H 2-(1-methyl-1-piperidynethyl 78 u 
(569) H 4-C(CH3 ) 3 -C 6H4 -CH2 62 u 
(570) H 4-C1.06 H4'  CHC6 H 5 52 
u 
(571) H CH3CH(OH)CH2 74 u 
(572) H H0-(CH 2 ) 2 - 67 u 
(573) H H0-(CH 2 ) 3 - 78 u 
(574) H CH 2 -C 6H 5 - 377,378 
(575) H CD2-C 6H 5 - 376 
(576) H CH-(CH3 ) 2 - 374,376,377 
(577) H C(CH3 ) 3 - 376,377 
(578) H H 35 374,376,377 
'(579) H CN 55 377,381 
(580) CH3 CH3 - 380 
(581) OCH3 CH3 - 380 
(582) Br CH3 - 380 
• 9 
(585) 
014 
(584) 
96 
(560) 
	
(561) 
 CH3 
The cyano compound (579) was prepared
377,381 
by the reaction of 
(560) and cyanamide in dimethylsulfoxide containing sodium hydride. 
The 5,6-dihydro-7H,12H-dibenz[c,f]azocine (578) was obtained by 
heating the dihydrochloride of (583) at 300 0 , in a sealed tube 
containing water.
377 
Then this was converted into many other 
derivatives. 382-386 
The structural studies of (577),
387 
(580)
388 
and (582),
389 
and 
nmr studies of (562)
390 
also were reported. 
B(ii)-(3) Dibenz[b,f]azocines  
The action of heat on compound (584) gave the dibenz[b,f]azocine-
6,11-dione (585). 391 
R (589) R 	C588) 
2% HC1 , 
-------> k526) 
(527) 
97 
(C) Photocyclization  
C-(1) Dibenz[c,e]azocines  
Photolysis of aryl iodides in benzene provided a new route for 
the synthesis of substituted biphenyls. Irradiation of the 
hydrochloride of N-(0-phenethyl)-2-iodobenzylamine (586a) in water 
for 113 hours gave the photocyclized product (526) in 25% yield, 
together with 10% of N-(0-phenethyl)benzylamine. 341 ' 392 The structure 
of (526 ) was established by the comparison with an authentic sample. 
The prolonged irradiation of (586a) gave a slightly improved yield 
(33%) of compound (526). The N-methyl derivative (586h) also gave 
the corresponding ring closed product (527) in 33% yield together 
with three other by-products (587-589). 
(586) 
(a) R = H 
(b) R = CH 3 
It has been suggested
341 
that the photolysis of (586) proceeds 
through the formation of an aryl radical by the homolysis of the 
carbon-iodine bond. The proposed mechanism is given in Scheme 21. 
The formation of (587) supports this mechanism. The drawback 
of this photocyclization reaction is the long reaction times. 
However, in contrast to the above results, irradiation of (590) for 
ten hours, followed by acetylation, gave 6,11-diacetoxy-2,3-methylene- 
OH 
(590) ( 591) (592) 
9 
N-C-CH 3 
9 
CH3-C-0 HO 
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(586) 
a, R = H 
b, R = CH3 
(526) 1 
or 
(527) X = halogen 
Scheme 21 
H20 
OH 
• dioxy-5,6,7,8-tetrahydrodibenz[c,e]azocine (592) in 22% yield, and 57% 
of the starting material was recovered. Furthermore, it was found 
that the length of the reaction could be shortened to two hours 
without decreasing the yield, by using a Corex filter.
341 
- 
Recently Kobayashi and Kihara
393396 
 described the photolysis of 
similar iodo-amines. Irradiation of (593a) in aqueous solution gave 
2,3-dimethoxy-5,6,7,8-tetrahydrodibenz[c,e]azocine (537) in 42% yield. 
99 
The dibenz[c,e]azocines (533, 538 and 540) also were prepared similarly 
from the iodo-amines (594a-596a) respectively. 393 
CH3 	0 
H x 
• ON/ Cr-j 
OCH3 
(593) a) X = I 
(594) (595) (596) 
b) IX = Br 1 180 hrs 11 217 hrs 1433 hrs 
(537) 42% (533) 5.1% (538) 5.8% (540) 53% 
On irradiation, the bromo-amines (593h-596h) also gave 40% of 
(537), 7% of (533), 8% of (538) and 11% of (54O).  
irradiation periods of bromo-amines were between forty minutes and 
nine hours. 
From these results, it is evident that the yields of the 
dibenzazocines (537,540) obtained from the halides having a halogen 
atom in the benzyl group (593,596) were better than those of the 
dibenzazocines (533,538) which were obtained from the halides 
•(594,595) having a halogen atom in the phenethyl group. Attempted 
cyclization of N-(3,4-methylenedioxybenzy1)-2-iodo-t3-phenethylamine 
(597) by irradiation was unsuccessful.393 
(597) 
100 
The suggested
394 
mechanism for the photocyclization with the halogen 
in the phenethyl group is shown in Scheme 22. 
R2 
Scheme 22 	(533) or (538) 
Yonedo et a1397 reported that the irradiation of (598) in 
aqueous sodium hydroxide gave a mixture of (599) and (600) in 37% and 
15% yield respectively. Compound (601) was prepared similarly. 
R1: 
101 
CH .0 
(598) 	 (599) R=H, R 1 =0H, R2=CH3 
(600) R=OH, R 1 =0H, R2=CH3 
(601) R=OH, R1 =H, R2=H 
Similar results were observed, when (598) was irradiated in a 
solution of sodium nitrite and 10% sulfuric acid.
398 
C-(3) Dibenz[b,f]azocines  
The photolysis of cycloheptatriene (602a) gave 4% of the 
dibenz[b,f]azocine (603a) together with 58% of (604a). 399 The major 
product (604a) was formed by nitrene insertion into the C 5-R bond 
(path A), and the dibenzazocine (603a) was formed by insertion into 
the C-C bond of the seven-membered ring (path 8). The photolysis of 
(602b) gave (604b) as the only identifiable product and (602c) gave 
14% of dibenzazocine (603c) and 46% of (604c). 
(602) 
a, R = C6H 5 
b, R = H 
c, R = 1-naphthyl 
102 
7 
	10 11 	
1 
-N2 
(604) 
C-(4) Dibenz[c,f]azocines  
Irradiation of (605) and N-bromosuccinimide in the presence of 
benzoyl peroxide gave a low yield (4%) of the lactam (606). 378 
(605) 
	
(606) 
	CH 2 C6 H 5 
(D) From bridge-head compounds  
(D)-(1) Dibenz[c,e]azocines  
When galanthamine (607a) was treated with potassium hydroxide and 
hydrazine hydrate in diethylene glycol at 200° it afforded the 
(558) (557) 
R
1 
R
2 
R
3 
a; OH H CH
3 
b; H OH CH
3 
1 HC1 
OH 
H
2
SO4/HC1 
HBr 
HC1 
HBr 
HBr 
103 
dibenzazocine (558), together with three other products. 400  The 
compound (558) was obtained from (607a) by heating with hydrochloric 
-acid
400 
 and was synthesised in moderate yield from (607b) by heating 
with 12% hydrochloric acid.
400,401 	
The reactions involved in the 
transformation
402 
are illustrated in Scheme 23. 
Scheme 23 
The triacetate derivative (486) was prepared by rearrangement of 
(609) in the presence of acetic anhydride and 98% sulfuric acid.315 
104 
OH (609) 
CH 0 
CH 0 
(CH3C0) 20/98% H2SO4 
N—COCH3 
OCOCH3 (486) 
(D)-(2) Dibenz[c,f]azocines  
The dibenz[c,f]azocines (610) and (612) were obtained from 
compound (611) by the Hofmann and the von Braun reactions 
respectively.
402 
(CH3 ) 2SO4 
NaOH 
A 
(610) 
 
(611) 
	
(612) 
The bridge-head compound (611) was prepared by the intramolecular 
Friedel-Crafts reaction of (613).
402 
HC104 
> (611) 
(613) 
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Chapter 6  
Dibenzodiazocines  
Only five out of the eleven possible isomers of dibenzadiazocines 
(A-E) have been synthesised so far and the commonest isomer is the 
dibenzo[10,f][1,5]diazocine [A] (Figure 15). 
[c,g][1,2] 
(C) 
[e,g][1,4] 	 [d,f][2,3] 
(D) Figure 15 (E) 
The most widely used preparative method in constructing this ring 
system was the dimerization (self-condensation) of 2-aminobenzophenone 
derivatives. Other synthetic methods employed Were similar to those 
previously described for the benz- and dibenzazocine compounds. 
Methods of preparation  
(A) Ring enlargements  
Ring enlargement types used for the synthesis of dibenzazocines 
are the (a) Beckmann rearrangement 
106 
(b) rearrangement of quinazolines 
(c) ring enlargement followed by cleavage of an 
internal bond, 
and (d) other ring enlargements. 
However the application of these methods are few, and limited to the 
construction of dibenz[b,f][1,5],[b,f][1,4] and P,fg[1,2]diazocines 
(isomers (A), (B) and (C) respectively). 
A(a) Beckmann rearrangement  
A(a)-(1) Dibenz[b,f][1,5] and [1,4]diazocines  
The Beckmann rearrangement of dianthraquinone dioxime (615) in 
the presence of polyphosphoric acid gave dibenzo[b,f][1,5]diazocine-
6,12-(5N,11N)-dione (616) and dibenzo[b4[1,4]diazocine 6,11- 
(5s, 1211)-dione (618).
403-405 
The dioxime (615) was prepared by the 
reaction of o-aminobenzoic acid (614) and hydroxylamine hydrochloride 
in refluxing pyridine.
404 
(Scheme 24). The dibenzo[b,f][1,5]azocine 
(616) was converted into several N-substituted derivatives. 406 011is
• and co-workers
303,407,408 
reported on the conformational analysis of 
(617). 
The reactions409 and the mass spectral fragmentation of diketone 
(616) 410 have also been reported. 
A(b) Rearrangement of quinazolines  
A(b)-(1) Dibenzo[b,f][1,5]diazocines  
Treatment of the quinazoline (619a) with methyl iodide or methyl 
bromide in chloroform for two days at room temperature, followed by 
three hours refluxing, afforded the ring expanded product (620).
411,412 
When the reaction mixture was refluxed over six hours most of the 
(1) NH2OH.HC1/pyridine 
02H (2) H 2SO4 
A 8 hours 
CH3 CH3 
CH 3 
(619) a; R = CH 3 
b; R = H TI 
CH 3 
H3 
3 N CH3 
1 
(620)R = CH 3 
(621)R = COCH 3 
CH 
Scheme 25 
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(614) 
	
\OH (615) 
1 
(616)R = H 
(617)R = CH 2 C6H 5 
(618) 
Scheme 24 
starting material was recovered.
412 The suggested mechanism for the 
rearrangement is shown in Scheme 25. 
(623) 
 
CH CO_) H 
3 0 
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In the presence of acetic anhydride, the quinazoline (619b) also 
underwent the same rearrangement giving rise to dibenzo[b,f][1,53- 
diazocine (621) and the bridge-head compound (622) which is commonly 
known as Troger's Base. 413 
CH
3 
CH
3 
(622) 
A(c) Ring enlargement followed by cleavage of an internal bond  
A(c)-(1) Dibenzo[b,fg[1,4]diazocines  
In the presence of 30% hydrogen peroxide in acetic acid, the 
compound (623) underwent an oxidative cleavage of the C-C bond common 
to rings B and C, giving rise to 30% of dibenzo[b,f][1,4]diazocine-
6,12-(5H, 1110-dione (618), together with a small amount of 0-nitro 
aniline. 414 
The proposed mechanism is given in Scheme 26. 
9 
CH -C-0 
3 
\O 
-H
+ 
Scheme 26 
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A(d) - Other ring enlargements  
A(d)-(1) Dibenzo[b,f][1,5]diazocines  
The ring enlargement of the dibenzo[b, e][1,4]oxazepine (624), 
in the presence of sodium hydride in benzene and dimethylformamide 
gave 40% of the dibenzo[b,f][1,5]diazocine-6,12-dione (625). 415 
(624) 
The diazocine derivative (625) may have formed through nucleophilic 
attack by the nitrogen anion on the carbonyl group. (Figure 16). 
Figure 16 
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A(d)-(2) Dibenzo[b,f][1,4]diazocines  
The reaction of (626) with dry ammonia afforded 51% of 5,12- 
dihydrobenzo[b,f][1,4]diazocine-6,12-dione (618).
416 	Derivatives of 
the corresponding tetrahydrodibenzo[5 41][1,4]diazocine, were also 
prepared.
301 
A(d)-(3) Dibenzo[d,f][1,2]diazocines  
The reaction of hydrazine hydrate with diphenic anhydride (627) 
followed by subsequent ring closure at 200° under vacuum, afforded 
the dibenzo[d,f][1,2]diazocine-5,8-(6H,7H)-dione (630).
417-422 
Similarly, the 3-nitro derivative (631) also was prepared. 418 The 
6-substituted dibenzo[d,f][2,3]diazocines (632-635) were synthesised 
by the reaction of (627) and N-substituted hydrazine hydrates of type 
(629).
419,420 
(B) Ring closure  
Ring closure of tye types a) C-N and 
b) N-N have been employed to 
synthesise many dibenzodiazocine derivatives. The more widely used ring 
closure is the C-N type. The few preparative methods involved with 
the formation of a C-C bond will be discussed later in the self- 
condensation section. A few workers
423,424 
have reported that 
the attempted Bischler-Napieralski reaction of amide (636) with 
polyphosphoric acid was unsuccessful; the final product obtained by 
111 
(627)R 1 =H 
(628)R 1 =NO2 
(629)R-NH-NH 2 •H 20 
(R=CH3 , C2H 5 , C3 H7' C4H9 ) 
(630)R1 =R2=R3=H 
(631) R 1 =NO2 , R2=R3=H 
(632) R 1 =R3=H; R2=CH3 
(633) R 1 =R3=H, R2=C2H 5 
(634) R1 =R3=H, R2=C3H 7 
(635) R 1 =R3=H, R2=C4H9 
this reaction was (637). No other work on ring closures of the C-C 
type seem to have been reported so far. 
CH 3 
PPA 
150° 
 
CH 3 
(636) R = CH 3' C6H 5 
	(637) 
B(a) C-N type  
The reaction types A and B, shown in the Figure 17 have been 
used for the formation of a C-N bond. 
Ring closure of type (A) results in the formation of dibenzo[b,f]-
[1,5]- and [1,4]-diazocines, while ring closure of type (B) results in 
the formation of dibenzo[e,g][1,4]diazocines. 
(B ) 
112 
Figure 17 
B(a)-(1) Dibenzo[b,f][1,5]diazocines  
Topliss and co workers
423
'
425 
have reported the formation of 
8-chloro-6-phenyl-11-methyl-dibenzo[b,f][1,5]diazocine-12-one (639) 
in 69% yield by the reductive cyclization (638a) in the presence of 
ammonium chloride in 2-methoxyethanol and water containing iron 
filings. Dibenzo[b,f][1,5]diazocines (640-642) were prepared 
similarly.
425 	
Under the same reaction conditions the N-unsubstituted 
nitro compound (638b) did not undergo the cyclodehydration giving 
rise to the expected dibenzodiazocine (640). The final product 
obtained was (645). Attempted cyclization of the amine with acetone 
gave a quinazoline derivative (646). However the dibenzodiazocine 
(640) was obtained in 95% yield, by refluxing the amine (645) in 
xylene for 6 hours.
423 	
Nakano and co-workers
426 
reported the 
synthesis of (643) by azeotropic dehydration of (638b) in pyridine. 
The 5,6-dihydro derivative (647) was obtained either by 
reduction of (638a) with 5% palladium charcoal in ethanol at room 
temperature for seven hours or with platinum oxide in glacial acetic 
acid at room temperature. The longer reaction periods resulted in 
the formation of (644) instead of the expected dibenzodiazocine 
(647).423 
Cl 
C 
i CH3 H C6H 5 
( 646) 
113 
Cl Cl C l 
(638) 
a: R=CH3 
b: R=H 
(639)R=CH3 , R1 =H, R2=C6H 5 
(640)R=R 1 =H, R2=C6H 5 
(641)R=(CH3 ) 2N(CH3 ) 2 , R1 =H, 
R
2
=C6H 5 
(642)R=(CH 3 ) 2N(CH3 ) 2 , R 1 =R2=H 
(643). R=H, R 1 =C1, R2=C6H 5 
(644) R=CH3 
(645) R=H 
C l C l 
 
(647) 
 
(648) 
These wor kers424-425 also tried to obtain (639) from the amide 
(648) by the Bischler-Napieralski reaction., However the attempted 
cyclodehydration with polyphosphoric acid only gave the benzoxazone 
(649). 
NH4Cl/Fe 
H 30(CH 2 ) 2O1 
Cl 
(653) (652) 
114 
The dione derivative (651) was obtained by the intramolecular 
cyclization of compound (650). 427 
SO2 CH3 
(650) (651) 
B(a)-(2) Dibenz[b,f][1,4]diazocines  
The reductive cyclization of (652) in the presence of ammonium 
chloride and iron filings gave 29% yield of the dibenz[b,f][1,4]- 
diazocine derivative (653).
423,425 
Saunders and Sprake
424 
synthesised 11,12-dihydro-12-p-tolyl-
dibenzo[b,f][1,4]diazocine-6(5H)-one (655) in 73% yield by the 
reaction of (654a) and sodium hydride in dioxane. Treatment of the 
amino acid (654b) with dicyclohexylcarbodiimide in ethyl acetate or 
ethyl 2-ethoxy-1,2-dihydroquinoline-1-carboxylate in tetrahydrofuran, 
also gave (655) in 64% yield.424 
CH
2
Br 
CH 2Br 
(656) (657-669) 
R
2 
R3 
(670-682) 
2 
(697-703) (692-695) 
115 
CH
3 
(654) (a) R=C2H 5 (655) 
(b) R=H 
A number of dibenzoD,A[1,4]diazocines (670-682 and 697-703) (Tables 
15 and 16) were synthesised by the reaction of o-phenylenediamine 
derivatives (657-669, 684-691) and a,a'-dibromo-o-xylene (656) 
(Table 15) or with 0-diketobenzene compounds (692-695) (Table 16). 
The general reactions are given in the Scheme 27. 
Scheme 27 
116 
Table 15  
B(a)-(2) Dibenzo[b,j1[1,4]diazocines  
(C-N type ring closure) 
Starting materials Reaction conditions' Products Yield 
% 
Reference 
NHR
2 
N Ri 
0 +2 I. 
 
NHR . 110 S 
• N 
(657-669) 
RI 	R2 	R3 R1 	R2 	R3 
(657) H CH3 CH3 anhydrous K2CO3/toluene (670) H CH3 CH3 85 428-431 
(658) H Is Ts reflux (671) H Is Ts 85 431 
(659) H S02C6H5 S02C6H KOH/H20 reflux 8 hours (672) H S02 .C6H 5 S02 .C6H5 90 432 
(660) Cl Ts Ts (673) Cl Is Is • - 430 
(661) OCH3 Ts Is in boiling toluene (674) OCH3 Ts Ts - 
. (662) CF 3 Is Is .. (675) CF3 Ts Ts - 
(663) NO2 Is Ts II (676) NO2 Ts Is - II 
(664) 0CH3 S02 .C6H 5 Ts . (677) OCH 3 S02 .C6H 5 Is - . . 
(665) OCH3 Ts S02 .06H5 
. (678) 0CH3 Is S02 .06H5 
(666) H CH3 CH3 K2CO3/toluene reflux (679) H CH3 	CH3 - 433 
(667) H COCH3 COCH3 (680) H COCH3 COCH3 . 
(668) H CHO CHO DMF/K2CO3/N2 reflux (681)
* 
 H CHO CHO 60 434 
(669) Cl CHO CHO 
. (682) Cl CHO CHO 77 435 
(683) H H CHO 
*The reaction of 85% potassium hydroxide with (681) (Table 13) yielded (683) 434 and this was further 
converted into several 12-substituted dibenzo[b,f][1,4)diazocine derivatives.441 
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Table 16" 
B(a)-(2) 0ibenzo[ban[1,4]diazocines 
(C-H type ring closure) 
Starting materials Reaction conditions Products Yield % Reference 
fel 	
H 
10111 NH2 
(684)R1 -12 H 	+ (692) R3=R4 =H 
(685)R1=R2=11 	+ (693) R3=R4 =C6H5 
(686)R1 =CH3 , R2=H 	+ (693) 
(687)R1 =C2H5 , R2=H 	+ (693) 
(688)R1 =iso-C3H7 , R2=H + (693) 
'(689) 11 1 =C1. R2=H 	+ (693) 
(690) 111 =R2=C1 	+ (693) • 
(684) . 	* (694) R3=R4 =C1 
(684) 	+ (695) R3=R4=0C2H5 
. 
•
NHCH3 + 
	110 NHTs 
• . 
A1C1 3/C1.C6H5 
p.013C6H4 .503H/// . 
C6H6/reflux 
, 	 a 
NaH/dimethyl 
formamide 
5% NaH in anhydrous dioxane 
.._ 	•, 
	
el 	
....._ 
__ 	1101 
(697)111 	R4=11 
(698)R1 -R2=H, R3=R4 =C6H5 
3. 	. (699) rill =CH ' 	R2=H 	R3=R4=C6H5 
(700)R1=C2H5' R2=11, R3=R4=C6H5 
(701)Ri =1so-C3H7' R2=H, R3=R4=C6H5 
,(702) 111 =C1. R241, R3=R4=C6H5 
(703) R1 =R2=C1,,R3=R4=C H" 65 
. 	 (61s) 
(618) 
ai3 	0 I N 
1 * 
I Ts 
(704) 
- 
72 
73 
69 
72 
73 
72 
- 
- 
91 
' 
436 
436-438 
438 
" 
° 
" 
" 
439 
. 440 
424 
Br' 
0 
(691) 	(699) 
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The starting materials, reaction conditions and yields of the 
dibenzo[b,f][1,4]diazocines obtained are recorded in Tables 15 and 
16. 
Ruxer and co-workers have reported the interconversions of 
(699),442 while others have reported kinetic 443 and structural 444,227 
studies on the dibenzo[b4][1,4]diazocines (697 and 698). 
The reduction of dione (618) with phosphorus pentachloride, 
hydrazine and copper acetate afforded (697),
440 
and the mass spectral 
behaviour of this compound has been reported.
445,446 
The 6,6-dideutero derivative of (704) was prepared by the 
reduction of (704) with lithium tetradeutero aluminate.
447 
B(a)-(3) Dibenzo[e,g][1,4]diazocines  
Many workers
448-457 
have reported the preparation of 6,7-diphenyl-
dibenzo[e,g][1,4]diazocine (707) in 70-80% yields by the interaction 
of 2,2'-diaminodiphenyl (705) and phenanthraquinone (706) in the 
presence of glacial acetic acid under reflux, for one hour to twenty-
four hours. 
 
 
(705) (706) 
 
(707) 
Similarly several other dibenzo[e,g][1,4]diazocine derivatives 
(720-731) (Table 15) were prepared.
459-468 	
The reaction conditions 
and the products obtained are tabulated in Table 17. 
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Table 17  
B(a)-(3) Dibenzo[e.0011,41diazocines 
(C-N type ring closure) 
Starting materials Reaction conditions Products Yield 
% 
Reference 
. 
 
S 112 
0 C6H5 
+ 
C6H5 
	
11111 	H 
R3 
(708 R:=R2=H 
R =CO2 il 
(709)R1 =CH3 , R2=R3=H 
(710)R1 =R3=H, R2=8r 
(711)R 1 =R2=11,.0 =CO2CH3 
(712)R1 =R3=F, R2 =H 
(713)+ 0 	6N43 , 
R 1 =R2=R3=H 
2 R1 
643 P 
. H2 
+ biacetyl 
4H2 
R to 
1 	2 	R3 	R4 	R5 R6 R R 
(714)CH3 CH3 HHHH 
(715)H H CH3 CH 3 H H 
(716)CO2HHHHHCO2H 
41111 
N HTs Br 
+. ;) 
NHTs Br 
glacial acetic acid 
A 24 hours 
in boiling propionic 
acid 
acetic acid 
a 
8 hours 
30 minutes/A 
in ethylene glycol 
1 hour, t 
Na in butanol 
dry toluene/reflux 
. 
(720) 
(721) 
(722) 
(723) 
(724) 
(725) 
(726) 
(727) 
(728) 
(729) 
(730) 
COI) 
3 
. 
" IP
Rh 
R 
N" 
lilt 
.3 
R:=R = , 123=C021-1 
R =H 
R1 =CH3 , R2=R3=H4 =H 
R 1 =R3=R4=H, R2=Br ' 
,. .=.., 
R3=CO2CH3 R I R2 R4 m 
RI =R3=F, R2=R4=H 
R1 =R2 =R3=H, R4 =CH3 
RI 
IP \ C 
R4 
40 
.6 
R
1 	R2 	R4 	R5 	P6 
CH3 CH3 HHHH 
H H CH3 CH3 H H 
CO211HHHHCO2H 
Is ip 
 
fik14 I Is 
H 
// H 
fli 
RC H 
R 
R=11 
73 
24 
— 
20 
- 
- 
- 
- 
39 
9 
24
.43 
82 
. 
77 
451,453, 
456,458 
459 
460 
451,456 
460 
455. 
451,456 
461 
462 
460 
460 
463 
464 
466,466 
467 
410 
(717) R 
"...:..... 
. LNu 2 
 
NH2 
(718) R=CO 5 + oxaly1 
chloride 
A119) R=11 + oxalic 	acid 
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B(a)-(4) Dibenzo[d,f][1,2]diazocines  
The dibenzo[d,f][1,2]diazocine (630), which was obtained by the 
ring enlargement of diphenic anhydride, was also synthesised by the 
reaction of the methyl ester (732) or dichloride (733) with hydrazine 
hydrate.
417,468 
(732) X = OCH3 
(733) X = Cl 
(734) X = CH3 
(735) X = H 
(736) X = C6H 5 
(630) Z = 0 
(737) Z = 0 
(738)  
The tetrahydro derivative (737) was prepared in 38% yield by 
the reaction of (738) with tert-butyl hydrazodiformate and potassium 
469 
in butanol and dimethylformamide. Compound (630) was further 
converted into N-substituted derivatives.
470 
• The condensation of diketone (734) with aqueous hydrazine hydrate 
gave 53% of the dibenzodiazocine (739), along with 4% of the 
phenanthrene derivative (741a).
471,472 
Under the same reaction 
conditions, the dialdehyde (735), gave (741b) as the only product. 
The 5,8-diphenyl derivative (740) was synthesised in 60% yield, by 
the reaction of (736) with hydrazine in diethylene glycol, and the 
473,474 
formation of by-products was not observed. 
121 
R R 
(739)R = CH 3 (741) a, R = CH 3 
(740)R = C6H 5 b, R = H 
A paper by Beaven and Johnson
475 
described the uv spectrum of 
(739). 
B(b) N-N type ring closure  
B(b)-(1) Dibenzofc,g][1,2]diazocines  
The reductive ring closure of N,N'-dinitrobibenzyl (742) with 
zinc dust in barium hydroxide and ethanol under reflux, gave 
5,6,11,12-tetrahydrodibenzojc,g][1,2]diazocine (743) in 60% 
yield 
476-48O 
Treatment of (743) with dilute acids afforded a spiro -1,2,3,4 - 
tetrahydroquinoline derivative, 481 and the reaction of (743) with 
methyl iodide gave (744).
482 
Neugebauer and Wegar
483 
have reported 
the [SR spectrum of this methylated derivative. 
1110 NO2 NO2 N --N 
I I 
R R - 
(743)R = H 
(744)R = CH3 
(742) 
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In the presence of yellow mercuric oxide in ethanol, (743) gave 
81% of 6,12-dihydrodibenz[c,0[1,2]diazocine (745), which was 
converted into (746),
476 
and (747),
484 
by a series of reactions. 
(745) 
R R 
(746) R = H 
(747) R = CH3 
With butyl lithium and methyl sulfate, (745) underwent a 
485,486 
dimerization reaction giving rise to (748).
482 Gersson et al 
described the ultraviolet absorption spectrum of (745). 
(748) 
(C) Self-condensation (dimerization)  
(C)-(1) Dibenzo[b,f][1,5]diazocines  
Self-condensation of 2-aminobenzophenone derivatives is the most 
widely employed method for the synthesis of dibenzo[b,f11,5]diazocines. 
In 1896, Sandheimer
450 
obtained a dimeric product by heating 
2-aminobenzophenone hydrochloride (749) alone. This compound was 
described as a "phenhomazine" derivative, now known as 6,12-diphenyl-
dibenzo[b,f][1,5]diazocine (750). 
C6H 5 
(750) 
0 
NHC-C 6H 5 
(751) (752) 
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In 1966, Metlesics and co-workers 487 reported the synthesis of 
the same dibenzodiazocine (750) in 71% yield by.the self-condensation 
of (749) in the presence of a catalytic amount of aluminiuM1 chloride 
in refluxing chlorobenzene. Replacing aluminium chloride with zinc 
chloride, a poor yield (22%) of (750) together with two minor 
by-products (751,752) were obtained.
488,489 
A 100% yield of (750) was isolated by heating 2-aminodiphenyl-
methyleneimine (753) at 200° in a nitrogen stream.
490 
Phosphorus 
oxychloride also was used as a catalyst for this bimolecular•
condensation. 491 
A patent by Yamamoto492 et al reported the synthesis of (750) in 
yields of 41-85%, but the experimental details were not given. 
NH2 
C = NH 
C6H 5 
(753) 
Other dibenzo[b,A[1,5]diazocines (787-818) prepared by the self-
condensation reactions
487-500 
 are given in Table 18. 
Many other dibenzo [b,f][1,5]diazocines were prepared by the 
bimolecular condensation of 2-aminobenzoic acid derivatives. For 
124 
example, 5,11-dihydroxydibenzo[b,f]diazocine (823) was synthesised 
from 2-aminomethylbenzoate (819). 5509 (Table 18). The 
reaction was carried out in benzonitrile containing "powdered" sodium 
in benzene, to give 55-60% yield of (823) together with two other 
products (820,821).
509,512 
(Scheme 28). Replacing benzonitrile 
with acetonitrile, the yield of (823) decreased and the reaction with 
sodium in benzene or ethanol alone gave a poor yield (4%) of 
(823) 508509 Hence this reaction could not be a simple base-catalysed 
condensation as thought at first, and it is possible that 
benzonitrile may act as a catalyst. In contrast to these results, 
6,12-demethoxydibenzo[b,f][1,5]diazocine (824) was obtained in 81% 
yield by the condensation of (831) in the presence of glacial acetic 
acid.
508 
The decomposition of (822) to (823) was similar to that 
observed in a number of open-chain analogues having the structure, 
1 
1 1 
C6H 5 	C6H5 
0 CH3 	6H5CEN 
Na in boiling 
NI-I 2 	C6H 6 
A 24 hrs (819) 
,,,C6H 5 HN :=C u 
0 
C = NH 
(822) 
	C6H 5 
Na
+ 
02 CH3 
N=C-NHNa 
' 
C H 6 5 	, 
•••■•11 ."(821) 
125 
(823) R = OH 
(824) R = OCH 3 
(825) R = 0C2 H 5 
(826) R = S02 -C6H 5 
(827) R = Cl 
(828) R = NH 2 
(829) R = NH.NH 2 
(830) R = H 
(831) 
Scheme 28 
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(C)-(I) Dibenzofb,(111,51diazocines 
(Self-condensation) 
R 1 
Table 18  
 
R7 
Starting material 
 
 
Product (R i to R7 as with the 
starting material) 
Starting material Solvent Catalyst Reaction (h) 
time or t°C 
Product Yield % Reference 
(754) R3 =C1 
• 
(755)R3=F 
(756)R3=Br 
(757)R3 =CF3 
(758)R3 =OCH3 
(759) R3 =8r, R54 
.- 
xylene 
- - 	• - _ - 
C6H 5C1 
C6H5CI 
xylene - 
heating in a N2 
Ce5C1 - 
C6H5C1 
Ce5C1 - 
C6H 5CI 
benzene 
heating in a nitrogen 105H5C1 
IIC 6H5Cl 
BF3 -(C2H5 ) 20 
ZnC1 2 
ZnC1 2 
ZnC1 2 
ZnC1 2 - 
A1C1 3 
Al C1 3 	. 
PPA 
HSO3 .06H -p-Me 
POC1 3 
stream 
BF3-Et20 , 
POC1 3 
AlC1 3 
BF3-Et30 
POC1 3 
AlC1 3 
. 	TiC1 4 
stream 
BF3/(C2H5 ) 2 0 
AlC1 3 
81
3
-(C H ) 0 
6/15 hr 
1800  
200° 
200° 
2400  
200° 
2000  
3 hr 
18 hr 
16 hr 
reflux 
17 hr 	1 
reflux 	j — 
17 hr 	i 
reflux 
2 hr 	1 
6 hr 	1 - 
16 hr 	i _ 
(787)  , 
(787)
* 
« 
" « 
0 « « 
._, 
(788)  - 
(789)  
(790;)] 
(790b) 
(791) 
88 
68 - 
43 
10 
8 
42 
78 - - 
62 
41- 
85 _ 
65 - - 
23 - - 
23 - 
65 - 
63 - 
487,492,493 
488,489 
493-496 
493 
497 
496 
498,499 
487,492,493 
491 
495 
487,492,493 
491 
495,496 
487,493 
498,499 )492 
487 
492,493, 
495 
487,492,493 
When not specified R n =H. 	(n=1,2,3,4,5, or 6) 
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Table 18 continued 
(760) R
3
.C1, R
5
.0013 fC51i 5C1 
. 
8F3 -(C 2H 5 ) 2 0 - 16. hr j (792) 43 
(761) R3R6°C1 . . 0 (793) 64 
(762) 113=C1, R7 °F * " 0 (794) 76 
487,492,493 
(763) R7.C1 . " I I (795) 84 
(764) R4 °C1 " " 0 (796) 52 
(765) R2=R3 .C1  ' (797) 64 , 
(766) R 3=R5=C1 " TiCI 4 " (798) 60 487,493 
(767) R3 =C1, R5=CH3 (799) 60 
. 
87 
. 
(768) R3=NO2 heating in a nitrogen stream _ 498,499 
AlC1 3 18 hr -. 493 
(800) 87' 
- POC1 3 reflux - 491 
xylene BF3-(C2H5 ) 20 15 hr - 492 
(769) R3=C2H5S C6H5CI TiC1 4 reflux (801) - 493 
(770) 111 =C1 ° BF3-T1C1 4 16 hr (802) 52 487,493 
(771) R I 0R3=Br ° , BF3/T1C1 4 " (803) 63 " 
(772) Ri =R2,13=114=c1 
" BF3/TiC1 4 reflux (804) - - 493 
- POC1 3 -, - 491 . 
(773) R3=CH3 - ZnC1 2 200° (805) 18 488 
ZnC1 2 220° 11.4 '489 
'xyl:ne 8F3rEt20 15 hr — 492 
Et0H HC1 A' 50 500' 
(774) R3=C1, R7 =CH3 heating in a nitrogen stream (806) 498,499 
(775) R3=C1, R7=OCH3 toluene and p-toluenesulfonic acid 16 hr (807) - 497 
(776) R7=0CH3 C6H5CH3/HSO3 .06H4 -P-CH3. - (8C9) - 
(777) R7=NO2 - POC1 3 (809) 491 
(778) R6=NO2 - H reflux (810) 41%- . 
85% 
(779) R500=R7=Br - . 1 1 (811) " 0 
(780) R 5°C1 - (812) " . 
NH 2 * structures of 
11111 C:= NH 
• the products 
101 are given 
( 781 -786) " below 
P. 1  
16'3 
Table 18 continued 
R R
1 
(781) Cl C6H5 heating in a N 2 
stream at 220° 
— 
. 
4 hr (813) - 490,492 
(782) NO2 C6H5 
. - n (814) —, 
Is 
(783) CF3 C6H5 
II . (815) - 
n 
(784) Cl o-tolyl 
. — . (816) - 
. 
(785) H 2-thienyl xylene BF3-(C2H 5 ) 20 15 hr (817) - 492 
(786) H 2-pyridyl 
. . (818) - 499 
The  reduction of (787) (paget26) afforded 2,8-dichloro-6,12-dipheny1-5,6-dihydro and 5,6,11,12-tetrahydrodibenzo-
P,f][1,5]diazocine.
501-504 
Ruxer and co-workers
505 reported on the NMR spectrum of (787), and the pharmacological studies showed that (787) 
possessed significant antigonadotropic activity in rats.
506,507 
/4HC) 
(00 C —C6H 5 
fTh/ 
C --N 
(823) (616) 
N --C, 
H 
OH 0 
0 1-1 
(823) 
/ 
(832) OH 
Figure 18 
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On the basis of this assumption, these workers have proposed the 
following mechanism for the decomposition of (822). (Scheme 29). 
Scheme 29 
A thermochromic rearrangement (Figure 18) has also been 
observed
513 
for the dibenzodiazocine (823). 
The compound (823) can be obtained from the hydrolysis of (826) 
which was prepared from the self-condensation of o-arylsulphonamido 
benzyl chloride. 509 The reaction of (823) with phosphorus 
pentachloride resulted in the formation of 6,12-dichlorodibenzoD,A- 
[1,5]diazocine (827). This was further converted into diamino (828) 
and dial koxy (824 and 825) derivatives by treatment with methanolic 
ammonia or by reaction with an appropriate alkoxide respectively.
509 
(Scheme 28). 
A paper by Pakrashi 514 described the synthesis of the diamino 
derivative (828) directly from the self-condensation of anthranilamide 
130 
(833) in anhydrous xylene and phenylacetic acid containing excess 
phosphorus pentoxide. Formation of several other by-products was 
a disadvantage of this method. Under the same reaction conditions, 
N-methylanthranilamide (834) did not give an eight-membered ring 
product. In addition to these methods, 6,12-diaminobenzoD,A[1,5]- 
diazocine (828) can be prepared from the self-condensation of 
o-cyanoanilinium toluene-p-sulphonate (835).
510 
CN 
CH3 
NH2 
(833) R = H (835) 
(834)R = CH3 
The reaction of 6,12-dichlorodibenzo[b,f][1,5]diazocine (827) 
with hydrazine gave (829) which afforded (830) on reduction with 
copper acetate.
515 	
Reduction of (830) followed by alkylation gave 
derivatives of 5,6,12-tetrahydrodibenz[b,Adiazocine.
513,516 
The formation of 5,6,11,12-tetrahydrodibenzo[b,f][1,5]diazocines have 
been achieved by the self-condensation of a-diamines of type (A). 
(836-840). The reaction of (836) either in benzoic acid in pure dry 
chloroform or benzoyl chloride in chloroform afforded 2,5,8,11- 
tetramethyldibenzo[b,f][1,5]diazocine (620). The former method gave 
a higher yield (70%) than the latter method. 411 
Similarly dibenzoD,A11,5jdiazocines (841-844) were prepared 
from the corresponding diamine (837-840).
411 	When the benzene rings 
of the a-diamine were unsubstituted (838-840), the yield of 
dibenzodiazocines (842-844) were only 35-40%, whereas a-diamines 
131 
12 
(836) R 1 =R2=CH3 (620) 
(837) R 1 =CH3 , R2=C2H5 (841) 
(838) R 1 =H, R2=C 6H5 (842) 
(839) R 1 =H, R2 .=CH3 (843) 
(840) R 1 ..H, R2=C2H 5 (844) 
R 1 =R2=CH3 
R 1 =CH3 , R2=C2H 5 
R1 =H, R2=C6H 5 
R 1 =H, R2=CH3 
R 1 =H, R2=C2H 5 
having substituents on the benzene rings (836,837) gave 70% yield of 
the corresponding diazocine (620,841). 
The suggested mechanism for the condensation of a-diamines 
unsubstituted on the benzene ring is illustrated in Scheme 30. 
Other dibenzo[b,f][1,5]diazocines (869-896) obtained by dimerization
517-532 
are summarized in Table 19. 
The dibenzo[b,f][1,5]diazocines (893-895) were prepared by the 
reaction of paraformaldehyde and saccharine with 0,m, and p-hydroxy 
aniline respectively.
534 
In the presence of aluminium chloride, 
silver tetrafluoroborate, or boron trifluoride-ethereate, the 
• 2-phenylbenzoazetes (896a,b)gave a mixture of dibenzo[b,f][1,5]- 
diazocine (750,807) and an angular dimer (897).
535 
(896) R.= H or 
R = CH 3 
132 
a-diamine (836-840) 
0 
=CH :N :N
R
/ 
2 
(845 ) 
R2 
R
2 HN 
I / 
N —CH2 
dry CHC1 3 
aqueous HC1 
II 
(845) + (620,841-844) 
dibenzodiazocine 
derivative. 
(Scheme 30) 
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Table 19  
(C)-(1) Dibenzo(p,Afl ,5]diazocines  
(Condensation) 
Starting materials Reaction conditions ' Products Yield 
% 
Reference 
N ''' 
R6 
R3 S 	
N'R
7 
(846) R3=CH3 
(847) R6=R7=CH3 
(848) R3=CH3 , R6=H R7 =NH2 
('849) R3=R6=R7 =CH3 
(850) R3=R6=CH3 
, 
(851) R6=C6H5 
-R
4 
R
2 
. (852-bp7) 
(852) R3 =CH R4=C H 
3' 6 5 
•
, 
•
. 
40% formaldehyde conc. HC1 
and NaNO2/HC1, and cuprous 
chloride 
benzoyl peroxide 
ZnC1 2 
benzoyl peroxide in ethyl 
acetate or CHC1 3' N2 
or 
C6H6 	or CH3CN at 5-45
0  
oxidation Hg(II)acetate in 
acetic acid or copper(II) 
chloride in Et0H or MeCN [ 
40% HCHO 2N HC1 after 14 
days at 20°C 
•
• 
• 
HCHO 
aziridine/A1C1 3 
R
6 	
1 
I R 
N 
R1 
(869) R
3
=CH3 
(843) R
6
=C113 
in cumene (0°) 
in tetralin (0°) 
in decane 
(870) R
3
=CH3 , R1 =C6H5 , 
(620) R
3
=R
6
=C6H5 (page 
no 8-membered ring product 
obtained 
(620) R
3
=R
6
=CH 
(620) * R3=R6=CH3 and 
R
6
=N:CHC6H5 
107) 
was 
32 
70 
low 
- 
79 
- 
2 ' 50 
equal 
yields 
78 
30 
517 
410 
518 
519,520 
518 
" 
411  
521, 
522 
523 
524 
 
N H 
CH3 	I 
CH3 
HCH3 . 
(871) 
(872) R
6
=C6115 
R4 o 
N 
R2 N 
(873-878) 14 
R 
°  
(873) R4 =C 6H5 
On addition of excess formaldehyde to the reaction mixture, the compound (871) was rapidly converted into (620). 
The formation of (871) was observed at low acid concentration. At higher acid concentration (>2N) only (872) was 
obtained. 5Z2 • 
1 34 
Table 19 continued 
• 
• 
0=C] 
(853) 3=CH 3 
R4 =C6H 5 il
R 
1-R:=H 
(854)R4=CH3 
- 
R 2=C1 
(855)R3=H 
R4 =C6H5 1_
(856)11) =OCH3 
(857)R2=OCH3 
(Oil+ 
 
R 
SO2 CI 
(858)R1 =112=H + (859) R5=OCH3 
(858) 	+ 	(860) R6=NO2 
(858) 	+ 	(861) R5=R6=R = 
CH3 	- 
(857) 	+ 	(8621 6 
R =CH 3 (856) 	+ 	(862) 
CONHOH • 011 02C1 
4- 
../ 
(863 
41111 
	
H 	R1 
(864)R=CH3, R1 =OCH3 
(865)R=CH 2CH3 ,12 1 =CN 
(866)R=CH(CH3 ) 2 
(867)R=C(63 ) 3 
02H R7 41111R  
- 
AlC1 3bziridine 
. 
S0C1 2 /C6H6 A/2 hours 
condensation 
p-CH3C6H4 S02C1 
in pyridine 30 0  to 114° 
. 
pyridine 	' 
.. 
., 
" 
. 
in alkali 
• 
xylene •  
• reflux 
(874)  
(875)  
(876)  
(878) 
(880) 
(881)  
(882) 
(883) 
(884) 
(866) 
(887)  
(888) 
(889) 
(877t1 =OCH 
1. 
R1 =C1, R6=C6H 5 
1 
R4=CH3 
R2=C1, R4=C6H5 
3 
R4=S02-C6H4 -p-CH3 
R2=OCH3 
A 
R'=S02-C6H4-p-CH3 
4- 0 
0 	o . 
N lilt 
NH 
.6 
1. 
o 
11111 
o 
R5=OCH3 R6 
R6=NO2 
R5=R5=R7 =CH3 
R 2=0CH3 , R5=CH3 
R1 =0CH 3 , R6=CH3 
R /I 
N 
N * 
o 
R 
R = S02-C 6H 5 
R=CH3 
R=CH2CH3 
R=6H(CH 3 ) 2 
R=C(CH3 ) 2 
' 
28 
50 
_ 
45 
15 
3 
67 
31 
- 
- 
- 
- 
- 
524 
525 
527 
527 
528 
529 
.. 
n 
" 
530 
531 
., 
n 
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Table 19 continued 
CI 
(868) 
S 
I N 
N 
H 
+anhydrous 
diglyne 
CI 110 
H 
OH 
reflux 
' 
p-toluenesulfonic acid/ 
C2H 5OH and pyridine 
' . 
(890) 
. 
 14
1/41 
NI%11 
i 
0 CI 
Cl 	111111 __ 
(643) 
- 
70 
532 
- 533 
The reaction of (864) in refluxing xylene gave a mixture of dibenzodiazocine (886) and (891), and thermolysis 
of (865) gave (892) as the only isolable product. 531 
NHR 
COR 1  
(891) R=CH3 , R1 =0CH3 
(892) R=CH2CH3 , 11 1 =CN 
OH 
0 
R 5 	-CH 2-NHC 
SO 2 
1 	3 R = R = H, R2 = OH 
S02-NH 
R
1 
= R
2 
= H, R3 = OH 
H 0 
OH 
2 
OH 
136 
R2 	R3 = H 
R1  = OH 
R4 	-CH2-N-CH 2 OH 
(893) 
(894) 
OH 
R2 = -CH 2  - N -CH 2 	 N--CH 2 OH 
(895) 
A 
(898) 
9 
x-c C—X 
137 
The dibenzodiazocine (899) was obtained by the pyrolysis of 
(898). "5," 7 
X = imidazol-1-y1 (899) 1-imidazoyl 
(900) R=CO2H 
(901) R=CO2 CH3 
Hydrolysis of (899) gave (900) which was converted into the 
diester (901). 537 
C-(2) Dibenzo[e,g][1,2]diazocines  
Unlike the situation with the dibenzo[b,f][1,5]diazocines, 
dimerization reactions have not been widely used in constructing the 
dibenzo[c,0[1,2]diazocines. The only case reported was the 
dimerization of 2-nitrotoluene in alkali-tert-butoxide under a nitrogen 
atmosphere.
538 
However, this reaction also resulted in the formation 
of a small amount of dibenzo[e,g][1,2]diazocine (902). 
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(D) Photochemical preparations 
Photochemical reactions have been employed only to synthesise 
a few derivatives of dibenzolb,Adiazocine and dibenzo[b,g][1,5]- 
diazocines so far. These reactions always resulted in the 
formation of mixtures. Therefore as a preparative method, 
photolysis is not so widely used as the condensation reactions. 
D-(1) Dibenzo[b,f]E1 ,5]diazocines  
Irradiation of the benzo[c]isothiazole derivative (903) in 
methyl cyanide, with a pyrex-filtered medium pressure mercury arc 
lamp gave 39% of (787) along with 8% of 2-amino-5-chlorobenzophenone 
(904).
539 	
When the reaction was carried out in methanol, the only 
product isolated was (904). Hence the solvent appears to influence 
the course of the reaction. 
Cl 
Cl 
C6H 5 
(903) 
	
(787) (904) 
D-(2) Dibenzo[b,g][1,5]diazocines  
Photolysis of 8-oxo-8H-quinazolino[3,2-c]1,2,3-benzotriazine 
(905) in methanol gave 82% yield of dibenzo[b,g][1,5]diazocine (906) 
along with 9% of (907). Irradiation of (905) in different solvents 
• gave derivatives of dibenzofb,011,5]diazocines. 54° These are given 
in Table 20. 
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Table 20 
D-(2) Dibeno[!.,4][1,51diazocines 
Starting material Solvent Products Yield % 
H  
N 
.1 
4111 
. 
14101 R-- 
4 CH3 OH (906) R=OCH3 and 82 
4111) N IN 111111 1110 9 
(907a) 	0 
(905) iso-propyl alcohol (908) R=OCH(CH 3 ) 2 
and 
52 
(907a) 16 
, 
Tetrahydrofuran 
, 
. . + 
morpholine (909) R = N-morpholino 
and 
47 
111111)  
0 ■'i 
(910) 46 
\ 
el 
Tetrahydrofuran N 
0 	H (905) methylene chloride (911) 47 
+ 
\.- • 
(907a) 38' 
H 2SO4 
(907a) 
(61 6) 
Scheme 31 
(907a) 
(0 
N') 
(morpholine) 
0 
(907b) (912) 
H /H 2 0 
(616) 
(,) 
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Hydrolysis of the photo-product (907a) gave 95% of dibenzo 
[b,f][1,5]diazocine-6,12(5H,11H)dione (616). 
A suggested pathway for this ring enlargement, somewhat 
different from that proposed by Ege and co-workers
540 
 is given in 
Scheme 31. 
The morpholino derivative (912), was obtained in 99% yield from 
(907a), and acid hydrolysis of (912) gave the dione (616). 5" 
(E) From bridge-head compounds  
(E)-(1) Dibenzo[b,f][1,5]diazocines  
Methylation of compounds of type (A), derivatives of Trtiger's 
base, with dimethyl sulfate in alkali resulted in the fission of the 
endomethylene bridge giving rise to the corresponding dibenzodiazocine 
derivatives (Scheme 32). 
R" 
01-P 
(A) 
-CH20 
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The dibenzodiazocine derivatives obtained by this method are 
given in Table 21. 
Scheme 32 
(E)-(2) Dibenzo[b,f][1,4]diazocines  
Treatment of dimethylsulfate and sodium hydroxide with the 
bridge-head compound (926) afforded the dibenzo[b,f][1,4]diazocine 
(670). 421 
CCH3 )2SO4 
(670) 
NaOH 
(926) 
 
Polymers of dibenzodiazocines  
In the presence of polyphosphoric acid, 3,3'-benzidine-
dicarboxylic acid (927) gave a yellowish-brown, heat-resistant 
,459,546 
polymer •in 64% yield. The formation of eight-membered rings 
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Table 21 
(E)-(1) Diben:o[b,1][1,51diarocines 
(from bridge-head covounds) 
Starting material Reaction conditions Product Yield 
% 
Reference 
11 	12 
io 
9 
R I 3. 	1103 
5 
. (622) 1 R=CH3 , R1 =H 
(913) R=SCH 3 , R1 =H 
(914) R=613 , R1 =C1 
(915) R=R 1 =CH3 
(916a) R=0CH3 , R1 =H 
(916b) R=0C2H 5 , R1 =H 
(917) R=6H3 , R 1 =H 
(917) 
(918) R=OCH 2C6H 5 
(CH3 ) 2504 
CHC1 3ACH3 ) 2SO4 
(CH3 ) 2SO4 
(CH3 ) 2SO4/NaOH 
dioxane/H20 
HCHO/HC1 ' 
allylbromide 
p-toluenesulfonyl 
chloride 
CH3COOH/formalin 
R
3 
N 
1 
11 12 110 
e Si 
; R 
R 
96 
- 
- 
32 
75 
- 
- 
- 
- 
541 
.. 
0 
.. 
542 
541 
524 
543 
R 
(620) * 
(919) 
(920) 
(921) 
(922) 
(923) 
(924) 
(925) 
(926) 
N 
R2 
R=R2=CH3' R1 =R3=H 
R=SCH3' R1 =R3=H, R2=CH3 
R=R2=CH3' 11 1 =C1, R3=H 
R=R 1 =R2=CH3' R3=N 
fROOCH3, R 1 =H, R2=CH3 
R
3
=H 
R=0C2H 5' R 1 =H, R2=R3=CH3 
R=CH3' R1 =R3=H 
R
2
=CH2 -CH=CH 2 
fRCH3 . Ri =li 
R
2
=Ts 
R=OCH2C6H 5 
R
1
=3,9(OCH2 C6H 5 ) 2 
•(Position of 11 1 is not given). 
*
The crystal structure of (620) 544 and complex formation with Cu(II), Zn(II) and Ni(II) have also been reported. 545 
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containing two lactam links was suggested from infrared 
spectroscopy. 
NH2 
(927) 
tb,g][1,4] 
(0) 
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Chapter 7  
Dibenzoxazocines  
Out of the sixteen possible dibenzoxazocines, only eight (A-H) 
have been synthesised, and these are given in Figure 19. - 
[b ,g] [1,5] [c , f] [1 ,5] 
	
[b,e][1,4] 
(D) (E) (F) 
[b,f][1,4], 
(G) 
[b ,f][1,5] 
(H) 
Figure 19 
Unlike other benzo and dibenzo derivatives, dibenzoxazocines have not 
. been widely prepared. The preparative methods employed to synthesise 
these isomers are similar to those for benzoxazocines, i.e ring 
enlargements and ring closure reactions. 
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Ring enlargement reactions used are the Beckmann and the Schmidt 
reactions. Application of these were few and limited to the 
construction of dibenz-[e,g]11,4]- and [b,g][1,4]oxazocines. The other 
five isomers have been synthesised by ring closure reactions. 
The formation of a carbon-nitrogen bond is the most commonly used 
ring closure type, while the C-0 type ring closure was employed to 
synthesise a dibenz[b,A[1,5]oxazocine. The C-C type of ring closure 
has not been used for the synthesis of these ring systems. 
(A) Ring enlargements  
(A)a Rearrangements  
A(a) i Beckmann and the Schmidt rearrangements  
A(a) i - Dibenz[e,g][1,4]oxazocines  
Harrow and co-workers
547 
described the synthesis of dibenz[e,g][1,4]- 
oxazocine-7(8H)-one (930) from the oxepine (928), either by the Beckmann 
or by the Schmidt reaction. The Beckmann rearrangement of the oxime 
(929) with polyphosphoric acid afforded 71% yield of (930), whereas 
the Schmidt reaction with sodium azide in polyphosphoric acid or in 
concentrated sulfuric acid gave 38% and 58% of yields respectively. 
In both reactions the formation of isomeric products or fragmentation 
products were not reported although expected theoretically. A number 
of N-substituted dihydrobenzoxazocines (932) were prepared by the action 
of alkyl halides on N-sodio derivatives followed by reduction with 
lithium aluminium hydride. The reaction sequence is given in Scheme 33. 
A(a) i-(2) •Dibenz[b,g][1,4Joxazocines  
In a patent by Mashimo et al, 548 it was reported that under the 
usual Schmidt reaction conditions, (i.e. using sodium azide and 
(934) R = H 
(935) R = Cl 
(936) R = Cl 
(937) R = NR2R3 
- 	 (933) 
146 
(1) rearrange- 
ment 
0 (2) NaNH2 
(3) alkyl halide 
0 
LiA1H
4  
N 
/C0 
11  
(928) Z = 0 (930) R = H (932) R = alkyl or 
(929) Z = NOH (931 ) R =alkyl 0 0 
Scheme 33 
C-CH
2
C1,, C-CH
2
NC
2
H
5 
concentrated sulfuric acid in benzene), the dibenz[b,noxepine-5-one 
(933) gave the dibenz[b,g][1,4joxazocine-6-(5N)-one (934) in 67% yield. 
The 3-chloro derivative (935) was also prepared similarly. Unlike 
the benzoxazocines, the formation of tetrazole derivatives and the 
isomeric products were not recorded. 
The action of phosphorus pentachloride on lactams (934,935) 
afforded the 6-chloro derivative (936) which was further converted 
into the 6-amino derivatives (937)•
549 	
The N-substituted tetrahydro 
derivatives (938) were obtained by the reaction of lactams (934,935) 
with an alkyl halide followed by reduction.
550,551 
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0 
N_R 1 
(938) 
R = H or Cl 
R
1 
= alkylene, lower alkyl, 
morpholine, pyrrolidino group etc. 
(B) Ring closure  
(B) i C-N type  
B(i)-(1) Dibenz[e,g][1,4]oxazocines  
The action of heat on the amino acid (939) gave the 
dibenzoxazocine (940) by cyclodehydration.
552 	
Similarly five other 
benzoxazocines (941-945) were prepared from the corresponding amino 
acids. 
Cl 
NH
2 • 
0 
0—CH 
2 N`OH 
R
1 
N
s\e0 
2 
0 R3 
. (939) (940) R=C1, R 1 =R2=R3=H 
(941)R=R1 =R2=R3 =H 
(942)R2=CH3 , R=R1 =R3 =H 
• (943) R2=R3=CH3 , R=R1 =H 
• C944) R 2=C2H 5 , R=R 1 =R3 =H 
(945) R2=C6H5' R=R1=R3=H 
148 
B(i)-(2) Dibenzfb,g][1,5joxazocines  
As described for the dibenzje,nazocines, several dibenzfb,g][1,5]- 
oxazocines were prepared by the reaction of dibromo compound (946) with 
various primary amines.
553-561 	
An interesting feature of this 
reaction was the formation of a sixteen-membered ring product (955). 
The yields of the dibenzoxazocines obtained by this method were 
generally satisfactory, but the yield of (952) was only 10%.
553 
CH 
CH 2Br 
(946) (947) R=H, X=H 
+ R-NH 2 
	
(948) R=H, X=C1 
(949)R=C2H 5 
(950)R=CH3 
(951)R=CH 2-CH=CH 2 
(952)CH2C6H 5 
(953) (CH2 ) 20H 
(954) (CH 2 ) 30H 
    
H -N-CH 2 
H -N-CH 2 
(955) 
X = Cl or H 
The lactams (957 and 958) were prepared by the base catalysed 
cyclization of (956). 562 
B(i)-(3) Dibenzfb,f][1,4joxazocines  
In the presence of dicyclohexylcarbodiimide (DCC) and ethyl 
aceto acetate, the amino acid (959) afforded dibenz[b,A[1,5]oxazocine- 
CO
2
Et 
CH
2
-NH
2 
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(956) (957) R = H 
(958) R = Cl 
12(11N)-one (960) in 39% yield. 565-569 A similar preparative method 
was described previously for the synthesis of benzo[1,4]diazocines. 
(page 52). 
The lactam (960) was reduced to the secondary amine (961) and 
converted to. the N-substituted derivatives in fair yields.
563,565-568 
A dimeric product (962) was obtsined by the reaction of (960) and 
carbonyl chloride in a solution of toluene containing sodium 
hydride. 556,567  
NH 2 
OH 
(959) 
(960) R = H, Z = 0 
(961) R = H, Z = 2H 
0 
11 
C 	N 
(962) 
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Puar and co-workers
570 have reported the conformational and 
spectral behaviour of 6,11-dihydro-12N-dibenz[b,f][1,4]oxazocines 
(961). The mass spectral fragmentation of (961) also was reported. 571 
8(i)-(4) Dibenz[c,f][1,5]oxazocines  
In two patents, Yale and co-workers
572,573 
reported that the 
intramolecular cyclization of (963) in ethylene glycol gave an 85% 
yield of the dibenz[c,f][1,5]oxazocine (964). This was converted into 
various N-substituted derivatives (965-967) by reaction with the 
appropriate alkyl halide.
572-578 
Na0(CH2 ) 20H 
(CH2OH) 2 
1000 
(963) (964) R=H . NH 
(965)R=(CH3 ) 2NCH3 C-NH 2 
(966)R=(CH3 ) 2 N(CH3 ) 2 
(967)R=(CH2 ) 2N(CH3 ) 2 
(968)R=piperidinocarbonyl 
The dibenz[c,f][1,4]oxazocines (964,966,967), and dibenz[b,e][1,4] 
oxazocine (969) were mentioned in one patent by Yale and co-workers,
573 
although there seems to be an error in the starting material given in 
the abstract. 
0 
0 
CO
2
H CO 
CH
3 
(970) 
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(969). 
R = (CH 2 ) 2N(CH3 ) 2 
B(ii) C-0 type of ring closure  
B(ii)-(l) .Dibenz[b,f][1,5]oxazocines  
In the presence of N,N'-carbonyldimidazole or dicyclohexyl-
carbodiimide, the cyclization of (970) in dimethylformamide at 100 0  
gave 73% yield of dibenzo[b4][1,5]oxazocine dione (971). 579 
B(ii)-(2) Dibenz[b,f][1,2]oxazocines  
Johnstone and co-workers
580 have reported the mass spectral 
fragmentation of a dibenzid,A[1,2]oxazocine, but no preparative 
details were given. 
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